Cayman公司成立于1980年，在过去20多年的发展过程中，始终保持着为科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供2,138 多种生化和免疫试剂，涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外，还提供多种高质量试剂，如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求，合成复杂和不稳定分子。
品牌商名称：Cayman Chemical
：(734) 971-3335
地址：1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司：http://www.caymanchem。。ｃｏｍ/
世界*实验材料供应商Cayman正式授权上海起发为其中国代理，Cayman在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海起发一直秉承为中国科研客户带来的产品，的服务， 签约Cayman就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Cayman中国代理，Cayman上海代理，Cayman北京代理，Cayman广东代理，Cayman江苏代理 Cayman湖北代理, Cayman天津, Cayman黑龙江代理, Cayman内蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江苏代理, Cayman浙江代理, Cayman四川代理,
部分报价4
| 品牌 | 目录号 | 产品 | 规格 | 2015目录价 |
| Cayman2015 | 12046 | CID-2745687 | 50 mg | 6832 |
| Cayman2015 | 12047 | 25B-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 12047 | 25B-NBOMe (hydrochloride) | 25 mg | 2660 |
| Cayman2015 | 12047 | 25B-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 12048 | 2-methoxy Ketamine (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 12048 | 2-methoxy Ketamine (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 12048 | 2-methoxy Ketamine (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 12049 | Acetildenafil | 1 mg | 770 |
| Cayman2015 | 12049 | Acetildenafil | 10 mg | 6160 |
| Cayman2015 | 12049 | Acetildenafil | 25 mg | 13482 |
| Cayman2015 | 12049 | Acetildenafil | 5 mg | 3472 |
| Cayman2015 | 12050 | BW 245C | 1 mg | 770 |
| Cayman2015 | 12050 | BW 245C | 10 mg | 6160 |
| Cayman2015 | 12050 | BW 245C | 5 mg | 3472 |
| Cayman2015 | 120500 | CysLT1 Receptor Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 12052 | MAM2201 N-(5-chloropentyl) analog-d5 | 1 mg | 1736 |
| Cayman2015 | 12052 | MAM2201 N-(5-chloropentyl) analog-d5 | 5 mg | 7280 |
| Cayman2015 | 12052 | MAM2201 N-(5-chloropentyl) analog-d5 | 500 μg | 910 |
| Cayman2015 | 12054 | GSK-J1 (sodium salt) | 1 mg | 350 |
| Cayman2015 | 12054 | GSK-J1 (sodium salt) | 10 mg | 1932 |
| Cayman2015 | 12054 | GSK-J1 (sodium salt) | 5 mg | 1316 |
| Cayman2015 | 12054 | GSK-J1 (sodium salt) | 50 mg | 8750 |
| Cayman2015 | 12055 | BW 246C | 1 mg | 602 |
| Cayman2015 | 12055 | BW 246C | 10 mg | 4816 |
| Cayman2015 | 12055 | BW 246C | 5 mg | 2716 |
| Cayman2015 | 120550 | CysLT2 Receptor (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 12056 | GSK-J2 (sodium salt) | 1 mg | 392 |
| Cayman2015 | 12056 | GSK-J2 (sodium salt) | 10 mg | 2548 |
| Cayman2015 | 12056 | GSK-J2 (sodium salt) | 5 mg | 1470 |
| Cayman2015 | 12056 | GSK-J2 (sodium salt) | 50 mg | 10780 |
| Cayman2015 | 120560 | CysLT2 Receptor (N-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 12057 | Neopterin | 10 mg | 336 |
| Cayman2015 | 12057 | Neopterin | 100 mg | 2520 |
| Cayman2015 | 12057 | Neopterin | 50 mg | 1344 |
| Cayman2015 | 12058 | Propylhexedrine (hydrochloride) | 10 mg | 728 |
| Cayman2015 | 12058 | Propylhexedrine (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 12058 | Propylhexedrine (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 12059 | Clozapine | 100 mg | 756 |
| Cayman2015 | 12059 | Clozapine | 250 mg | 1470 |
| Cayman2015 | 12059 | Clozapine | 50 mg | 420 |
| Cayman2015 | 12059 | Clozapine | 500 mg | 2730 |
| Cayman2015 | 12060 | BW A868C | 1 mg | 980 |
| Cayman2015 | 12060 | BW A868C | 10 mg | 7840 |
| Cayman2015 | 12060 | BW A868C | 5 mg | 4410 |
| Cayman2015 | 12061 | 25H-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 12061 | 25H-NBOMe (hydrochloride) | 25 mg | 2660 |
| Cayman2015 | 12061 | 25H-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 12062 | 25H-NBOMe imine analog | 1 mg | 784 |
| Cayman2015 | 12062 | 25H-NBOMe imine analog | 10 mg | 6272 |
| Cayman2015 | 12062 | 25H-NBOMe imine analog | 5 mg | 3528 |
| Cayman2015 | 12063 | Etizolam | 1 mg | 616 |
| Cayman2015 | 12063 | Etizolam | 10 mg | 3696 |
| Cayman2015 | 12063 | Etizolam | 5 mg | 2002 |
| Cayman2015 | 12065 | AKB48 N-(5-fluoropentyl) analog | 1 mg | 490 |
| Cayman2015 | 12065 | AKB48 N-(5-fluoropentyl) analog | 10 mg | 3920 |
| Cayman2015 | 12065 | AKB48 N-(5-fluoropentyl) analog | 5 mg | 2212 |
| Cayman2015 | 12067 | N-Methyltryptamine | 10 mg | 952 |
| Cayman2015 | 12067 | N-Methyltryptamine | 25 mg | 2310 |
| Cayman2015 | 12067 | N-Methyltryptamine | 5 mg | 616 |
| Cayman2015 | 12068 | Δ9-THC | 10 mg | 938 |
| Cayman2015 | 12068 | Δ9-THC | 5 mg | 490 |
| Cayman2015 | 12068 | Δ9-THC | 50 mg | 3682 |
| Cayman2015 | 12071 | SR 1555 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 12071 | SR 1555 (hydrochloride) | 10 mg | 2128 |
| Cayman2015 | 12071 | SR 1555 (hydrochloride) | 25 mg | 4662 |
| Cayman2015 | 12071 | SR 1555 (hydrochloride) | 5 mg | 1190 |
| Cayman2015 | 12072 | SR 3335 | 1 mg | 350 |
| Cayman2015 | 12072 | SR 3335 | 10 mg | 2128 |
| Cayman2015 | 12072 | SR 3335 | 25 mg | 4662 |
| Cayman2015 | 12072 | SR 3335 | 5 mg | 1190 |
| Cayman2015 | 12073 | GSK-J4 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 12073 | GSK-J4 (hydrochloride) | 10 mg | 1932 |
| Cayman2015 | 12073 | GSK-J4 (hydrochloride) | 5 mg | 1316 |
| Cayman2015 | 12073 | GSK-J4 (hydrochloride) | 50 mg | 8750 |
| Cayman2015 | 12074 | GSK-J5 (hydrochloride) | 1 mg | 392 |
| Cayman2015 | 12074 | GSK-J5 (hydrochloride) | 10 mg | 2548 |
| Cayman2015 | 12074 | GSK-J5 (hydrochloride) | 5 mg | 1470 |
| Cayman2015 | 12074 | GSK-J5 (hydrochloride) | 50 mg | 10780 |
| Cayman2015 | 12076 | Canertinib (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 12076 | Canertinib (hydrochloride) | 25 mg | 2212 |
| Cayman2015 | 12076 | Canertinib (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 12076 | Canertinib (hydrochloride) | 50 mg | 3682 |
| Cayman2015 | 12077 | 1-hydroxy Vitamin D2 | 1 mg | 406 |
| Cayman2015 | 12077 | 1-hydroxy Vitamin D2 | 10 mg | 2688 |
| Cayman2015 | 12077 | 1-hydroxy Vitamin D2 | 5 mg | 1624 |
| Cayman2015 | 12078 | 25-hydroxy Vitamin D2 | 1 mg | 2730 |
| Cayman2015 | 12078 | 25-hydroxy Vitamin D2 | 5 mg | 11760 |
| Cayman2015 | 12078 | 25-hydroxy Vitamin D2 | 500 μg | 1470 |
| Cayman2015 | 12079 | 1,24-dihydroxy Vitamin D3 | 1 mg | 2366 |
| Cayman2015 | 12079 | 1,24-dihydroxy Vitamin D3 | 5 mg | 9968 |
| Cayman2015 | 12079 | 1,24-dihydroxy Vitamin D3 | 500 μg | 1246 |
| Cayman2015 | 12082 | 1-hydroxy Vitamin D3 | 1 mg | 406 |
| Cayman2015 | 12082 | 1-hydroxy Vitamin D3 | 10 mg | 2688 |
| Cayman2015 | 12082 | 1-hydroxy Vitamin D3 | 5 mg | 1624 |
| Cayman2015 | 12084 | CI-994 | 10 mg | 476 |
| Cayman2015 | 12084 | CI-994 | 5 mg | 252 |
| Cayman2015 | 12084 | CI-994 | 50 mg | 2016 |
| Cayman2015 | 12085 | Cladribine | 10 mg | 238 |
| Cayman2015 | 12085 | Cladribine | 100 mg | 1904 |
| Cayman2015 | 12085 | Cladribine | 50 mg | 1078 |
| Cayman2015 | 12086 | CPTH2 (hydrochloride) | 10 mg | 1442 |
| Cayman2015 | 12086 | CPTH2 (hydrochloride) | 5 mg | 1106 |
| Cayman2015 | 12087 | Crizotinib | 10 mg | 2310 |
| Cayman2015 | 12087 | Crizotinib | 5 mg | 1330 |
| Cayman2015 | 12087 | Crizotinib | 50 mg | 7700 |
| Cayman2015 | 12088 | Cyclosporin A | 100 mg | 770 |
| Cayman2015 | 12088 | Cyclosporin A | 25 mg | 350 |
| Cayman2015 | 12089 | 4-Bromomethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 12089 | 4-Bromomethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 12089 | 4-Bromomethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 12090 | Glimepiride | 1 g | 770 |
| Cayman2015 | 12090 | Glimepiride | 5 g | 2730 |
| Cayman2015 | 12090 | Glimepiride | 500 mg | 546 |
| Cayman2015 | 12091 | Epirubicin (hydrochloride) | 10 mg | 1232 |
| Cayman2015 | 12091 | Epirubicin (hydrochloride) | 100 mg | 8232 |
| Cayman2015 | 12091 | Epirubicin (hydrochloride) | 25 mg | 2744 |
| Cayman2015 | 12091 | Epirubicin (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 12092 | Etoposide | 100 mg | 672 |
| Cayman2015 | 12092 | Etoposide | 25 mg | 210 |
| Cayman2015 | 12092 | Etoposide | 50 mg | 378 |
| Cayman2015 | 12092 | Etoposide | 500 mg | 2100 |
| Cayman2015 | 12093 | Kaempferitrin | 1 mg | 660 |
| Cayman2015 | 12093 | Kaempferitrin | 5 mg | 2970 |
| Cayman2015 | 12094 | Lestaurtinib | 1 mg | 1288 |
| Cayman2015 | 12094 | Lestaurtinib | 10 mg | 10304 |
| Cayman2015 | 12094 | Lestaurtinib | 5 mg | 5796 |
| Cayman2015 | 12095 | Butyrolactone 3 | 1 mg | 602 |
| Cayman2015 | 12095 | Butyrolactone 3 | 5 mg | 2716 |
| Cayman2015 | 12096 | Mubritinib | 10 mg | 770 |
| Cayman2015 | 12096 | Mubritinib | 100 mg | 4872 |
| Cayman2015 | 12096 | Mubritinib | 5 mg | 406 |
| Cayman2015 | 12096 | Mubritinib | 50 mg | 2842 |
| Cayman2015 | 12098 | Tandutinib | 100 mg | 1596 |
| Cayman2015 | 12098 | Tandutinib | 25 mg | 616 |
| Cayman2015 | 12098 | Tandutinib | 250 mg | 3570 |
| Cayman2015 | 12098 | Tandutinib | 50 mg | 1050 |
| Cayman2015 | 12099 | 2,4,6-Trimethoxyamphetamine (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 12099 | 2,4,6-Trimethoxyamphetamine (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 12099 | 2,4,6-Trimethoxyamphetamine (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 12210 | 5-trans Prostaglandin D2 | 1 mg | 672 |
| Cayman2015 | 12210 | 5-trans Prostaglandin D2 | 10 mg | 5376 |
| Cayman2015 | 12210 | 5-trans Prostaglandin D2 | 5 mg | 3024 |
| Cayman2015 | 12215 | Hsp25/Hsp27 Monoclonal Antibody (Clone 8A7) | 100 μg | 4980 |
| Cayman2015 | 12215 | Hsp25/Hsp27 Monoclonal Antibody (Clone 8A7) | 25 μg | 2340 |
| Cayman2015 | 12410 | 11-deoxy-11-methylene Prostaglandin D2 | 1 mg | 798 |
| Cayman2015 | 12410 | 11-deoxy-11-methylene Prostaglandin D2 | 10 mg | 6384 |
| Cayman2015 | 12410 | 11-deoxy-11-methylene Prostaglandin D2 | 5 mg | 3598 |
| Cayman2015 | 12415 | 11-deoxy-11-methylene-15-keto Prostaglandin D2 | 1 mg | 5376 |
| Cayman2015 | 12415 | 11-deoxy-11-methylene-15-keto Prostaglandin D2 | 100 μg | 672 |
| Cayman2015 | 12415 | 11-deoxy-11-methylene-15-keto Prostaglandin D2 | 500 μg | 3024 |
| Cayman2015 | 12500 | EUK 124 | 10 mg | 672 |
| Cayman2015 | 12500 | EUK 124 | 100 mg | 4900 |
| Cayman2015 | 12500 | EUK 124 | 5 mg | 350 |
| Cayman2015 | 12500 | EUK 124 | 50 mg | 2800 |
| Cayman2015 | 12610 | 13,14-dihydro-15-keto Prostaglandin D2 | 1 mg | 1470 |
| Cayman2015 | 12610 | 13,14-dihydro-15-keto Prostaglandin D2 | 10 mg | 11760 |
| Cayman2015 | 12610 | 13,14-dihydro-15-keto Prostaglandin D2 | 5 mg | 6622 |
| Cayman2015 | 12650 | Δ12-Prostaglandin D2 | 1 mg | 1008 |
| Cayman2015 | 12650 | Δ12-Prostaglandin D2 | 10 mg | 7448 |
| Cayman2015 | 12650 | Δ12-Prostaglandin D2 | 5 mg | 4256 |
| Cayman2015 | 12650 | Δ12-Prostaglandin D2 | 500 μg | 532 |
| Cayman2015 | 12700 | 15-deoxy-Δ12,14-Prostaglandin D2 | 1 mg | 2100 |
| Cayman2015 | 12700 | 15-deoxy-Δ12,14-Prostaglandin D2 | 5 mg | 8848 |
| Cayman2015 | 12700 | 15-deoxy-Δ12,14-Prostaglandin D2 | 500 μg | 1106 |
| Cayman2015 | 12720 | 15(R)-15-methyl Prostaglandin D2 | 1 mg | 1008 |
| Cayman2015 | 12720 | 15(R)-15-methyl Prostaglandin D2 | 10 mg | 7448 |
| Cayman2015 | 12720 | 15(R)-15-methyl Prostaglandin D2 | 5 mg | 4256 |
| Cayman2015 | 12720 | 15(R)-15-methyl Prostaglandin D2 | 500 μg | 532 |
| Cayman2015 | 12730 | 15(S)-15-methyl Prostaglandin D2 | 1 mg | 1344 |
| Cayman2015 | 12730 | 15(S)-15-methyl Prostaglandin D2 | 10 mg | 10752 |
| Cayman2015 | 12730 | 15(S)-15-methyl Prostaglandin D2 | 5 mg | 6048 |
| Cayman2015 | 12750 | 16,16-dimethyl Prostaglandin D2 | 1 mg | 1092 |
| Cayman2015 | 12750 | 16,16-dimethyl Prostaglandin D2 | 10 mg | 8036 |
| Cayman2015 | 12750 | 16,16-dimethyl Prostaglandin D2 | 5 mg | 4592 |
| Cayman2015 | 12750 | 16,16-dimethyl Prostaglandin D2 | 500 μg | 574 |
| Cayman2015 | 12810 | 17-phenyl trinor Prostaglandin D2 | 1 mg | 812 |
| Cayman2015 | 12810 | 17-phenyl trinor Prostaglandin D2 | 10 mg | 6496 |
| Cayman2015 | 12810 | 17-phenyl trinor Prostaglandin D2 | 5 mg | 3654 |
| Cayman2015 | 12850 | tetranor-PGDM | 100 μg | 6650 |
| Cayman2015 | 12850 | tetranor-PGDM | 25 μg | 1848 |
| Cayman2015 | 12850 | tetranor-PGDM | 50 μg | 3514 |
| Cayman2015 | 12990 | Prostaglandin D3 | 100 μg | 2940 |
| Cayman2015 | 12990 | Prostaglandin D3 | 25 μg | 966 |
| Cayman2015 | 12990 | Prostaglandin D3 | 50 μg | 1610 |
| Cayman2015 | 13000 | Pterostilbene | 100 mg | 1862 |
| Cayman2015 | 13000 | Pterostilbene | 250 mg | 4410 |
| Cayman2015 | 13000 | Pterostilbene | 50 mg | 980 |
| Cayman2015 | 13000 | Pterostilbene | 500 mg | 7840 |
| Cayman2015 | 13002 | 2-methyl Benzamideoxime | 1000 mg | 644 |
| Cayman2015 | 13002 | 2-methyl Benzamideoxime | 500 mg | 336 |
| Cayman2015 | 13002 | 2-methyl Benzamideoxime | 5000 mg | 2688 |
| Cayman2015 | 13003 | 2-Pyridylamide oxime | 100 mg | 154 |
| Cayman2015 | 13003 | 2-Pyridylamide oxime | 1000 mg | 924 |
| Cayman2015 | 13003 | 2-Pyridylamide oxime | 250 mg | 350 |
| Cayman2015 | 13003 | 2-Pyridylamide oxime | 500 mg | 616 |
| Cayman2015 | 13004 | 3-Pyridylamide oxime | 100 mg | 154 |
| Cayman2015 | 13004 | 3-Pyridylamide oxime | 1000 mg | 924 |
| Cayman2015 | 13004 | 3-Pyridylamide oxime | 250 mg | 350 |
| Cayman2015 | 13004 | 3-Pyridylamide oxime | 500 mg | 616 |
| Cayman2015 | 13005 | 4-Pyridylamide oxime | 100 mg | 154 |
| Cayman2015 | 13005 | 4-Pyridylamide oxime | 1000 mg | 924 |
| Cayman2015 | 13005 | 4-Pyridylamide oxime | 250 mg | 350 |
| Cayman2015 | 13005 | 4-Pyridylamide oxime | 500 mg | 616 |
| Cayman2015 | 13006 | 3-methyl-2-Quinoxalinone | 1000 mg | 2170 |
| Cayman2015 | 13006 | 3-methyl-2-Quinoxalinone | 250 mg | 602 |
| Cayman2015 | 13006 | 3-methyl-2-Quinoxalinone | 500 mg | 1148 |
| Cayman2015 | 13006 | 3-methyl-2-Quinoxalinone | 5000 mg | 9632 |
| Cayman2015 | 13007 | ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate | 100 mg | 154 |
| Cayman2015 | 13007 | ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate | 1000 mg | 1232 |
| Cayman2015 | 13007 | ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate | 250 mg | 364 |
| Cayman2015 | 13007 | ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate | 500 mg | 700 |
| Cayman2015 | 13008 | Disuccinimidyl Suberate | 100 mg | 182 |
| Cayman2015 | 13008 | Disuccinimidyl Suberate | 250 mg | 448 |
| Cayman2015 | 13008 | Disuccinimidyl Suberate | 50 mg | 98 |
| Cayman2015 | 13008 | Disuccinimidyl Suberate | 500 mg | 784 |
| Cayman2015 | 13009 | GSK 264220A | 1 mg | 350 |
| Cayman2015 | 13009 | GSK 264220A | 10 mg | 1750 |
| Cayman2015 | 13009 | GSK 264220A | 25 mg | 3934 |
| Cayman2015 | 13009 | GSK 264220A | 5 mg | 1316 |
| Cayman2015 | 13010 | Prostaglandin E1 | 1 mg | 238 |
| Cayman2015 | 13010 | Prostaglandin E1 | 10 mg | 1428 |
| Cayman2015 | 13010 | Prostaglandin E1 | 5 mg | 1008 |
| Cayman2015 | 13010 | Prostaglandin E1 | 50 mg | 6552 |
| Cayman2015 | 13012 | Prostaglandin E1 Ethanolamide | 1 mg | 714 |
| Cayman2015 | 13012 | Prostaglandin E1 Ethanolamide | 10 mg | 5712 |
| Cayman2015 | 13012 | Prostaglandin E1 Ethanolamide | 5 mg | 3220 |
| Cayman2015 | 13013 | (-)-Blebbistatin | 1 mg | 406 |
| Cayman2015 | 13013 | (-)-Blebbistatin | 10 mg | 3248 |
| Cayman2015 | 13013 | (-)-Blebbistatin | 25 mg | 7112 |
| Cayman2015 | 13013 | (-)-Blebbistatin | 5 mg | 1722 |
| Cayman2015 | 13019 | 2-Hydroxyestradiol | 1 mg | 490 |
| Cayman2015 | 13019 | 2-Hydroxyestradiol | 10 mg | 4172 |
| Cayman2015 | 13019 | 2-Hydroxyestradiol | 25 mg | 9184 |
| Cayman2015 | 13019 | 2-Hydroxyestradiol | 5 mg | 2212 |
| Cayman2015 | 13020 | Prostaglandin E1 Alcohol | 1 mg | 686 |
| Cayman2015 | 13020 | Prostaglandin E1 Alcohol | 10 mg | 5096 |
| Cayman2015 | 13020 | Prostaglandin E1 Alcohol | 5 mg | 2912 |
| Cayman2015 | 13020 | Prostaglandin E1 Alcohol | 500 μg | 364 |
| Cayman2015 | 13021 | 2-Methoxyestradiol | 10 mg | 644 |
| Cayman2015 | 13021 | 2-Methoxyestradiol | 25 mg | 1512 |
| Cayman2015 | 13021 | 2-Methoxyestradiol | 5 mg | 336 |
| Cayman2015 | 13021 | 2-Methoxyestradiol | 50 mg | 2688 |
| Cayman2015 | 13025 | PDI Polyclonal Antibody | 100 μL | 5960 |
| Cayman2015 | 13025 | PDI Polyclonal Antibody | 25 μL | 2660 |
| Cayman2015 | 13031 | SB 431542 | 1 mg | 252 |
| Cayman2015 | 13031 | SB 431542 | 10 mg | 1512 |
| Cayman2015 | 13031 | SB 431542 | 25 mg | 3150 |
| Cayman2015 | 13031 | SB 431542 | 5 mg | 1134 |
| Cayman2015 | 13032 | PD 173074 | 1 mg | 280 |
| Cayman2015 | 13032 | PD 173074 | 10 mg | 1400 |
| Cayman2015 | 13032 | PD 173074 | 25 mg | 2800 |
| Cayman2015 | 13032 | PD 173074 | 5 mg | 840 |
| Cayman2015 | 13033 | Valproic Acid (sodium salt) | 10 g | 350 |
| Cayman2015 | 13033 | Valproic Acid (sodium salt) | 100 g | 1932 |
| Cayman2015 | 13033 | Valproic Acid (sodium salt) | 25 g | 574 |
| Cayman2015 | 13033 | Valproic Acid (sodium salt) | 50 g | 1050 |
| Cayman2015 | 13034 | PD 0325901 | 1 mg | 280 |
| Cayman2015 | 13034 | PD 0325901 | 10 mg | 1386 |
| Cayman2015 | 13034 | PD 0325901 | 25 mg | 2772 |
| Cayman2015 | 13034 | PD 0325901 | 5 mg | 700 |
| Cayman2015 | 13036 | 2-(3-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 1 g | 924 |
| Cayman2015 | 13036 | 2-(3-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 100 mg | 154 |
| Cayman2015 | 13036 | 2-(3-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 250 mg | 350 |
| Cayman2015 | 13036 | 2-(3-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 500 mg | 616 |
| Cayman2015 | 13042 | ApoA1 Monoclonal Antibody (Clone CC3821C4) | 1 ea | 2562 |
| Cayman2015 | 13043 | 2-Pyridylthioamide | 1 g | 98 |
| Cayman2015 | 13043 | 2-Pyridylthioamide | 10 g | 784 |
| Cayman2015 | 13043 | 2-Pyridylthioamide | 25 g | 1722 |
| Cayman2015 | 13043 | 2-Pyridylthioamide | 5 g | 448 |
| Cayman2015 | 13044 | Tranilast | 10 mg | 406 |
| Cayman2015 | 13044 | Tranilast | 5 mg | 210 |
| Cayman2015 | 13044 | Tranilast | 50 mg | 1680 |
| Cayman2015 | 13045 | ATB-343 | 1 mg | 392 |
| Cayman2015 | 13045 | ATB-343 | 10 mg | 3136 |
| Cayman2015 | 13045 | ATB-343 | 5 mg | 1764 |
| Cayman2015 | 13045 | ATB-343 | 50 mg | 13720 |
| Cayman2015 | 13047 | 2-(2-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 1 g | 924 |
| Cayman2015 | 13047 | 2-(2-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 100 mg | 154 |
| Cayman2015 | 13047 | 2-(2-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 250 mg | 350 |
| Cayman2015 | 13047 | 2-(2-pyridyl)-4-methyl-Thiazole-5-Carboxylic Acid | 500 mg | 616 |
| Cayman2015 | 13048 | Eicosapentaenoic Acid Quant-PAK | 1 ea | 1134 |
| Cayman2015 | 13049 | 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid | 1 g | 924 |
| Cayman2015 | 13049 | 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid | 100 mg | 154 |
| Cayman2015 | 13049 | 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid | 250 mg | 336 |
| Cayman2015 | 13049 | 2-(4-Pyridyl)-4-methyl-thiazole-5-Carboxylic Acid | 500 mg | 616 |
| Cayman2015 | 13050 | 1a,1b-dihomo Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13050 | 1a,1b-dihomo Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13050 | 1a,1b-dihomo Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13054 | 2-(3-pyridyl)-Benzimidazole | 1 g | 350 |
| Cayman2015 | 13054 | 2-(3-pyridyl)-Benzimidazole | 5 g | 1456 |
| Cayman2015 | 13054 | 2-(3-pyridyl)-Benzimidazole | 500 mg | 182 |
| Cayman2015 | 13055 | Naphthofluorescein | 1 mg | 308 |
| Cayman2015 | 13055 | Naphthofluorescein | 10 mg | 2464 |
| Cayman2015 | 13055 | Naphthofluorescein | 5 mg | 1386 |
| Cayman2015 | 13055 | Naphthofluorescein | 50 mg | 10780 |
| Cayman2015 | 13056 | 4-Pyridylthioamide | 1 g | 112 |
| Cayman2015 | 13056 | 4-Pyridylthioamide | 10 g | 896 |
| Cayman2015 | 13056 | 4-Pyridylthioamide | 25 g | 1960 |
| Cayman2015 | 13056 | 4-Pyridylthioamide | 5 g | 504 |
| Cayman2015 | 13057 | 3-methyl Benzamideoxime | 1 g | 742 |
| Cayman2015 | 13057 | 3-methyl Benzamideoxime | 5 g | 3136 |
| Cayman2015 | 13057 | 3-methyl Benzamideoxime | 500 mg | 392 |
| Cayman2015 | 13058 | N-Oleoyl-L-Serine | 1 mg | 196 |
| Cayman2015 | 13058 | N-Oleoyl-L-Serine | 10 mg | 1568 |
| Cayman2015 | 13058 | N-Oleoyl-L-Serine | 5 mg | 882 |
| Cayman2015 | 13058 | N-Oleoyl-L-Serine | 50 mg | 6860 |
| Cayman2015 | 13059 | ethyl-2-amino-4-methyl-Thiazole-5-Carboxylate | 1 g | 448 |
| Cayman2015 | 13059 | ethyl-2-amino-4-methyl-Thiazole-5-Carboxylate | 250 mg | 126 |
| Cayman2015 | 13059 | ethyl-2-amino-4-methyl-Thiazole-5-Carboxylate | 5 g | 2016 |
| Cayman2015 | 13059 | ethyl-2-amino-4-methyl-Thiazole-5-Carboxylate | 500 mg | 238 |
| Cayman2015 | 13060 | 17(R)-Resolvin D1 | 10 μg | 1750 |
| Cayman2015 | 13060 | 17(R)-Resolvin D1 | 100 μg | 13832 |
| Cayman2015 | 13060 | 17(R)-Resolvin D1 | 25 μg | 4158 |
| Cayman2015 | 13060 | 17(R)-Resolvin D1 | 50 μg | 7882 |
| Cayman2015 | 13061 | 2-amino-5-methyl-4-phenyl Thiazole | 1 g | 4032 |
| Cayman2015 | 13061 | 2-amino-5-methyl-4-phenyl Thiazole | 100 mg | 504 |
| Cayman2015 | 13061 | 2-amino-5-methyl-4-phenyl Thiazole | 250 mg | 1204 |
| Cayman2015 | 13061 | 2-amino-5-methyl-4-phenyl Thiazole | 500 mg | 2268 |
| Cayman2015 | 13063 | N-3-oxo-tetradecanoyl-L-Homoserine lactone | 1 mg | 336 |
| Cayman2015 | 13063 | N-3-oxo-tetradecanoyl-L-Homoserine lactone | 10 mg | 2688 |
| Cayman2015 | 13063 | N-3-oxo-tetradecanoyl-L-Homoserine lactone | 25 mg | 5880 |
| Cayman2015 | 13063 | N-3-oxo-tetradecanoyl-L-Homoserine lactone | 5 mg | 1512 |
| Cayman2015 | 13064 | N-hexadecanoyl-L-Homoserine lactone | 10 mg | 798 |
| Cayman2015 | 13064 | N-hexadecanoyl-L-Homoserine lactone | 25 mg | 1890 |
| Cayman2015 | 13064 | N-hexadecanoyl-L-Homoserine lactone | 5 mg | 420 |
| Cayman2015 | 13064 | N-hexadecanoyl-L-Homoserine lactone | 50 mg | 3360 |
| Cayman2015 | 13067 | SB 203580 | 10 mg | 2072 |
| Cayman2015 | 13067 | SB 203580 | 100 mg | 15288 |
| Cayman2015 | 13067 | SB 203580 | 5 mg | 1092 |
| Cayman2015 | 13067 | SB 203580 | 50 mg | 8736 |
| Cayman2015 | 13068 | Fucoxanthin | 10 mg | 1652 |
| Cayman2015 | 13068 | Fucoxanthin | 5 mg | 868 |
| Cayman2015 | 13068 | Fucoxanthin | 50 mg | 6510 |
| Cayman2015 | 13074 | Tosyllysine Chloromethyl Ketone (hydrochloride) | 100 mg | 1036 |
| Cayman2015 | 13074 | Tosyllysine Chloromethyl Ketone (hydrochloride) | 250 mg | 2464 |
| Cayman2015 | 13074 | Tosyllysine Chloromethyl Ketone (hydrochloride) | 50 mg | 546 |
| Cayman2015 | 13076 | 16(R)-Iloprost | 1 mg | 3248 |
| Cayman2015 | 13076 | 16(R)-Iloprost | 5 mg | 13664 |
| Cayman2015 | 13076 | 16(R)-Iloprost | 500 μg | 1708 |
| Cayman2015 | 13077 | 16(S)-Iloprost | 1 mg | 4872 |
| Cayman2015 | 13077 | 16(S)-Iloprost | 5 mg | 20496 |
| Cayman2015 | 13077 | 16(S)-Iloprost | 500 μg | 2562 |
| Cayman2015 | 13079 | ApoA1 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 13082 | Resorcinolnaphthalein | 10 mg | 420 |
| Cayman2015 | 13082 | Resorcinolnaphthalein | 100 mg | 3136 |
| Cayman2015 | 13082 | Resorcinolnaphthalein | 5 mg | 224 |
| Cayman2015 | 13082 | Resorcinolnaphthalein | 50 mg | 1792 |
| Cayman2015 | 13083 | ThioFluor 623 | 10 mg | 3668 |
| Cayman2015 | 13083 | ThioFluor 623 | 5 mg | 1932 |
| Cayman2015 | 13083 | ThioFluor 623 | 50 mg | 13524 |
| Cayman2015 | 13084 | STF-62247 | 1 mg | 210 |
| Cayman2015 | 13084 | STF-62247 | 10 mg | 1680 |
| Cayman2015 | 13084 | STF-62247 | 25 mg | 3682 |
| Cayman2015 | 13084 | STF-62247 | 5 mg | 952 |
| Cayman2015 | 13085 | Tenovin-1 | 10 mg | 686 |
| Cayman2015 | 13085 | Tenovin-1 | 100 mg | 5096 |
| Cayman2015 | 13085 | Tenovin-1 | 5 mg | 364 |
| Cayman2015 | 13085 | Tenovin-1 | 50 mg | 2912 |
| Cayman2015 | 13086 | Tenovin-6 | 1 mg | 1834 |
| Cayman2015 | 13086 | Tenovin-6 | 10 mg | 14672 |
| Cayman2015 | 13086 | Tenovin-6 | 25 mg | 32102 |
| Cayman2015 | 13086 | Tenovin-6 | 5 mg | 8260 |
| Cayman2015 | 13089 | Radicicol | 1 mg | 742 |
| Cayman2015 | 13089 | Radicicol | 5 mg | 3430 |
| Cayman2015 | 13089 | Radicicol | 500 μg | 490 |
| Cayman2015 | 13090 | Δ17-Prostaglandin E1 | 1 mg | 980 |
| Cayman2015 | 13090 | Δ17-Prostaglandin E1 | 10 mg | 7840 |
| Cayman2015 | 13090 | Δ17-Prostaglandin E1 | 5 mg | 4410 |
| Cayman2015 | 13093 | N-tridecanoyl-L-Homoserine lactone | 10 mg | 686 |
| Cayman2015 | 13093 | N-tridecanoyl-L-Homoserine lactone | 25 mg | 1638 |
| Cayman2015 | 13093 | N-tridecanoyl-L-Homoserine lactone | 5 mg | 364 |
| Cayman2015 | 13093 | N-tridecanoyl-L-Homoserine lactone | 50 mg | 2912 |
| Cayman2015 | 13094 | N-pentadecanoyl-L-Homoserine lactone | 10 mg | 798 |
| Cayman2015 | 13094 | N-pentadecanoyl-L-Homoserine lactone | 25 mg | 1890 |
| Cayman2015 | 13094 | N-pentadecanoyl-L-Homoserine lactone | 5 mg | 420 |
| Cayman2015 | 13094 | N-pentadecanoyl-L-Homoserine lactone | 50 mg | 3360 |
| Cayman2015 | 13100 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 10 μg | 1176 |
| Cayman2015 | 13100 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 100 μg | 9408 |
| Cayman2015 | 13100 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 25 μg | 2800 |
| Cayman2015 | 13100 | 13,14-dihydro-15-keto-tetranor Prostaglandin D2 | 50 μg | 5292 |
| Cayman2015 | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | 10 μg | 1120 |
| Cayman2015 | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | 25 μg | 2660 |
| Cayman2015 | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 | 50 μg | 5040 |
| Cayman2015 | 13102 | Skyrin | 1 mg | 2235 |
| Cayman2015 | 13103 | MAM2201 N-(5-chloropentyl) analog | 1 mg | 910 |
| Cayman2015 | 13103 | MAM2201 N-(5-chloropentyl) analog | 10 mg | 7280 |
| Cayman2015 | 13103 | MAM2201 N-(5-chloropentyl) analog | 5 mg | 4102 |
| Cayman2015 | 13104 | Streptozotocin | 1 g | 1425 |
| Cayman2015 | 13104 | Streptozotocin | 250 mg | 840 |
| Cayman2015 | 13104 | Streptozotocin | 50 mg | 375 |
| Cayman2015 | 13106 | Oxaliplatin | 100 mg | 1652 |
| Cayman2015 | 13106 | Oxaliplatin | 250 mg | 2772 |
| Cayman2015 | 13106 | Oxaliplatin | 50 mg | 868 |
| Cayman2015 | 13107 | Pimecrolimus | 10 mg | 280 |
| Cayman2015 | 13107 | Pimecrolimus | 100 mg | 2240 |
| Cayman2015 | 13107 | Pimecrolimus | 50 mg | 1260 |
| Cayman2015 | 13108 | VX-702 | 10 mg | 504 |
| Cayman2015 | 13108 | VX-702 | 25 mg | 1204 |
| Cayman2015 | 13108 | VX-702 | 5 mg | 266 |
| Cayman2015 | 13109 | Emodin | 100 mg | 1260 |
| Cayman2015 | 13109 | Emodin | 25 mg | 350 |
| Cayman2015 | 13109 | Emodin | 50 mg | 672 |
| Cayman2015 | 13111 | AZD 4547 | 10 mg | 1876 |
| Cayman2015 | 13111 | AZD 4547 | 5 mg | 1246 |
| Cayman2015 | 13111 | AZD 4547 | 50 mg | 6860 |
| Cayman2015 | 13112 | Carboplatin | 100 mg | 1260 |
| Cayman2015 | 13112 | Carboplatin | 25 mg | 350 |
| Cayman2015 | 13112 | Carboplatin | 250 mg | 2800 |
| Cayman2015 | 13112 | Carboplatin | 50 mg | 672 |
| Cayman2015 | 13113 | Cidofovir | 100 mg | 952 |
| Cayman2015 | 13113 | Cidofovir | 25 mg | 406 |
| Cayman2015 | 13113 | Cidofovir | 50 mg | 742 |
| Cayman2015 | 13115 | UR-144 N-(2-chloropentyl) analog | 1 mg | 3528 |
| Cayman2015 | 13115 | UR-144 N-(2-chloropentyl) analog | 100 μg | 448 |
| Cayman2015 | 13115 | UR-144 N-(2-chloropentyl) analog | 500 μg | 1988 |
| Cayman2015 | 13116 | UR-144 N-(3-chloropentyl) analog | 1 mg | 3528 |
| Cayman2015 | 13116 | UR-144 N-(3-chloropentyl) analog | 100 μg | 448 |
| Cayman2015 | 13116 | UR-144 N-(3-chloropentyl) analog | 500 μg | 1988 |
| Cayman2015 | 13117 | UR-144 N-(4-chloropentyl) analog | 1 mg | 3528 |
| Cayman2015 | 13117 | UR-144 N-(4-chloropentyl) analog | 100 μg | 448 |
| Cayman2015 | 13117 | UR-144 N-(4-chloropentyl) analog | 500 μg | 1988 |
| Cayman2015 | 13118 | Metformin (hydrochloride) | 1 g | 252 |
| Cayman2015 | 13118 | Metformin (hydrochloride) | 5 g | 378 |
| Cayman2015 | 13119 | Cisplatin | 100 mg | 644 |
| Cayman2015 | 13119 | Cisplatin | 250 mg | 952 |
| Cayman2015 | 13119 | Cisplatin | 50 mg | 406 |
| Cayman2015 | 13119 | Cisplatin | 500 mg | 1750 |
| Cayman2015 | 13120 | 2,3-dinor Prostaglandin E1 | 100 μg | 2268 |
| Cayman2015 | 13120 | 2,3-dinor Prostaglandin E1 | 25 μg | 630 |
| Cayman2015 | 13120 | 2,3-dinor Prostaglandin E1 | 50 μg | 1204 |
| Cayman2015 | 13121 | Sodium Butyrate | 100 g | 504 |
| Cayman2015 | 13121 | Sodium Butyrate | 250 g | 1204 |
| Cayman2015 | 13121 | Sodium Butyrate | 50 g | 266 |
| Cayman2015 | 13121 | Sodium Butyrate | 500 g | 2128 |
| Cayman2015 | 13122 | CHIR99021 | 1 mg | 532 |
| Cayman2015 | 13122 | CHIR99021 | 10 mg | 2604 |
| Cayman2015 | 13122 | CHIR99021 | 5 mg | 1386 |
| Cayman2015 | 13123 | BIO | 1 mg | 350 |
| Cayman2015 | 13123 | BIO | 10 mg | 1932 |
| Cayman2015 | 13123 | BIO | 25 mg | 4382 |
| Cayman2015 | 13123 | BIO | 5 mg | 1386 |
| Cayman2015 | 13124 | BIX01294 (hydrochloride hydrate) | 1 mg | 322 |
| Cayman2015 | 13124 | BIX01294 (hydrochloride hydrate) | 10 mg | 1932 |
| Cayman2015 | 13124 | BIX01294 (hydrochloride hydrate) | 5 mg | 1288 |
| Cayman2015 | 13124 | BIX01294 (hydrochloride hydrate) | 50 mg | 6440 |
| Cayman2015 | 13127 | GW 4869 (hydrochloride hydrate) | 1 mg | 560 |
| Cayman2015 | 13127 | GW 4869 (hydrochloride hydrate) | 10 mg | 3332 |
| Cayman2015 | 13127 | GW 4869 (hydrochloride hydrate) | 5 mg | 1904 |
| Cayman2015 | 13127 | GW 4869 (hydrochloride hydrate) | 500 μg | 322 |
| Cayman2015 | 13129 | trans-trismethoxy Resveratrol-d4 | 1 mg | 4368 |
| Cayman2015 | 13129 | trans-trismethoxy Resveratrol-d4 | 100 μg | 546 |
| Cayman2015 | 13129 | trans-trismethoxy Resveratrol-d4 | 250 μg | 1302 |
| Cayman2015 | 13129 | trans-trismethoxy Resveratrol-d4 | 500 μg | 2464 |
| Cayman2015 | 13130 | trans-Resveratrol-d4 | 100 μg | 546 |
| Cayman2015 | 13130 | trans-Resveratrol-d4 | 1000 μg | 4368 |
| Cayman2015 | 13130 | trans-Resveratrol-d4 | 250 μg | 1302 |
| Cayman2015 | 13130 | trans-Resveratrol-d4 | 500 μg | 2464 |
| Cayman2015 | 13131 | VER-49009 | 1 mg | 2184 |
| Cayman2015 | 13131 | VER-49009 | 10 mg | 16072 |
| Cayman2015 | 13131 | VER-49009 | 5 mg | 9184 |
| Cayman2015 | 13131 | VER-49009 | 500 μg | 1148 |
| Cayman2015 | 13132 | VER-50589 | 1 mg | 2184 |
| Cayman2015 | 13132 | VER-50589 | 5 mg | 9184 |
| Cayman2015 | 13132 | VER-50589 | 500 μg | 1148 |
| Cayman2015 | 13136 | N-acetyl-D-Glucosamine | 1 g | 238 |
| Cayman2015 | 13136 | N-acetyl-D-Glucosamine | 10 g | 1764 |
| Cayman2015 | 13136 | N-acetyl-D-Glucosamine | 5 g | 1008 |
| Cayman2015 | 13136 | N-acetyl-D-Glucosamine | 500 mg | 126 |
| Cayman2015 | 13139 | Imatinib (mesylate) | 100 mg | 1960 |
| Cayman2015 | 13139 | Imatinib (mesylate) | 25 mg | 546 |
| Cayman2015 | 13139 | Imatinib (mesylate) | 50 mg | 1036 |
| Cayman2015 | 13139 | Imatinib (mesylate) | 500 mg | 8736 |
| Cayman2015 | 13140 | 4-(n-nonyl) Benzeneboronic Acid | 1 g | 1568 |
| Cayman2015 | 13140 | 4-(n-nonyl) Benzeneboronic Acid | 100 mg | 196 |
| Cayman2015 | 13140 | 4-(n-nonyl) Benzeneboronic Acid | 250 mg | 462 |
| Cayman2015 | 13140 | 4-(n-nonyl) Benzeneboronic Acid | 500 mg | 882 |
| Cayman2015 | 13143 | CAY10587 | 1 mg | 364 |
| Cayman2015 | 13143 | CAY10587 | 10 mg | 2912 |
| Cayman2015 | 13143 | CAY10587 | 25 mg | 6370 |
| Cayman2015 | 13143 | CAY10587 | 5 mg | 1638 |
| Cayman2015 | 13144 | Anacardic Acid | 1 mg | 280 |
| Cayman2015 | 13144 | Anacardic Acid | 10 mg | 952 |
| Cayman2015 | 13144 | Anacardic Acid | 5 mg | 532 |
| Cayman2015 | 13145 | AGK2 | 1 mg | 350 |
| Cayman2015 | 13145 | AGK2 | 10 mg | 1932 |
| Cayman2015 | 13145 | AGK2 | 25 mg | 4382 |
| Cayman2015 | 13145 | AGK2 | 5 mg | 1232 |
| Cayman2015 | 13146 | CAY10603 | 1 mg | 1148 |
| Cayman2015 | 13146 | CAY10603 | 10 mg | 8428 |
| Cayman2015 | 13146 | CAY10603 | 5 mg | 4816 |
| Cayman2015 | 13146 | CAY10603 | 500 μg | 602 |
| Cayman2015 | 13151 | (E)-C-HDMAPP (ammonium salt) | 1 mg | 1624 |
| Cayman2015 | 13151 | (E)-C-HDMAPP (ammonium salt) | 10 mg | 11956 |
| Cayman2015 | 13151 | (E)-C-HDMAPP (ammonium salt) | 5 mg | 6832 |
| Cayman2015 | 13151 | (E)-C-HDMAPP (ammonium salt) | 500 μg | 854 |
| Cayman2015 | 13156 | Chaetocin | 1 mg | 2772 |
| Cayman2015 | 13156 | Chaetocin | 10 mg | 22176 |
| Cayman2015 | 13156 | Chaetocin | 5 mg | 12474 |
| Cayman2015 | 13158 | JZL 184 | 10 mg | 854 |
| Cayman2015 | 13158 | JZL 184 | 100 mg | 6272 |
| Cayman2015 | 13158 | JZL 184 | 5 mg | 448 |
| Cayman2015 | 13158 | JZL 184 | 50 mg | 3584 |
| Cayman2015 | 13159 | Sunitinib Malate | 1 mg | 420 |
| Cayman2015 | 13159 | Sunitinib Malate | 10 mg | 1330 |
| Cayman2015 | 13159 | Sunitinib Malate | 5 mg | 812 |
| Cayman2015 | 13159 | Sunitinib Malate | 50 mg | 1932 |
| Cayman2015 | 13160 | AT-56 | 1 mg | 462 |
| Cayman2015 | 13160 | AT-56 | 10 mg | 3696 |
| Cayman2015 | 13160 | AT-56 | 5 mg | 2086 |
| Cayman2015 | 13160 | AT-56 | 50 mg | 16170 |
| Cayman2015 | 13161 | 7-epi Maresin 1 | 10 μg | 1078 |
| Cayman2015 | 13161 | 7-epi Maresin 1 | 100 μg | 8624 |
| Cayman2015 | 13161 | 7-epi Maresin 1 | 25 μg | 2562 |
| Cayman2015 | 13161 | 7-epi Maresin 1 | 50 μg | 4858 |
| Cayman2015 | 13164 | CAY10589 | 1 mg | 602 |
| Cayman2015 | 13164 | CAY10589 | 10 mg | 4816 |
| Cayman2015 | 13164 | CAY10589 | 5 mg | 2716 |
| Cayman2015 | 13165 | (+)-Blebbistatin | 1 mg | 406 |
| Cayman2015 | 13165 | (+)-Blebbistatin | 10 mg | 3248 |
| Cayman2015 | 13165 | (+)-Blebbistatin | 25 mg | 7112 |
| Cayman2015 | 13165 | (+)-Blebbistatin | 5 mg | 1722 |
| Cayman2015 | 13166 | Gefitinib | 1 g | 3332 |
| Cayman2015 | 13166 | Gefitinib | 250 mg | 924 |
| Cayman2015 | 13166 | Gefitinib | 5 g | 14784 |
| Cayman2015 | 13166 | Gefitinib | 500 mg | 1750 |
| Cayman2015 | 13168 | Splitomicin | 1 mg | 350 |
| Cayman2015 | 13168 | Splitomicin | 10 mg | 1232 |
| Cayman2015 | 13168 | Splitomicin | 25 mg | 3066 |
| Cayman2015 | 13168 | Splitomicin | 5 mg | 700 |
| Cayman2015 | 13169 | JWH 018 (exempt preparation) | 10 mg | 1120 |
| Cayman2015 | 13169 | JWH 018 (exempt preparation) | 25 mg | 2520 |
| Cayman2015 | 13169 | JWH 018 (exempt preparation) | 5 mg | 630 |
| Cayman2015 | 13170 | JWH 073 (exempt preparation) | 10 mg | 1120 |
| Cayman2015 | 13170 | JWH 073 (exempt preparation) | 25 mg | 2520 |
| Cayman2015 | 13170 | JWH 073 (exempt preparation) | 5 mg | 630 |
| Cayman2015 | 13171 | JWH 200 (exempt preparation) | 10 mg | 1484 |
| Cayman2015 | 13171 | JWH 200 (exempt preparation) | 25 mg | 3528 |
| Cayman2015 | 13171 | JWH 200 (exempt preparation) | 5 mg | 784 |
| Cayman2015 | 13172 | CBHA | 10 mg | 1750 |
| Cayman2015 | 13172 | CBHA | 25 mg | 2758 |
| Cayman2015 | 13172 | CBHA | 5 mg | 924 |
| Cayman2015 | 13173 | DAz-1 | 1 mg | 1484 |
| Cayman2015 | 13173 | DAz-1 | 10 mg | 11872 |
| Cayman2015 | 13173 | DAz-1 | 5 mg | 6678 |
| Cayman2015 | 13174 | M 344 | 10 mg | 1386 |
| Cayman2015 | 13174 | M 344 | 25 mg | 3276 |
| Cayman2015 | 13174 | M 344 | 5 mg | 728 |
| Cayman2015 | 13174 | M 344 | 50 mg | 5824 |
| Cayman2015 | 13175 | Farnesyl Thiosalicylic Acid Amide | 1 mg | 196 |
| Cayman2015 | 13175 | Farnesyl Thiosalicylic Acid Amide | 10 mg | 1568 |
| Cayman2015 | 13175 | Farnesyl Thiosalicylic Acid Amide | 5 mg | 882 |
| Cayman2015 | 13175 | Farnesyl Thiosalicylic Acid Amide | 50 mg | 6860 |
| Cayman2015 | 13176 | Oxamflatin | 1 mg | 770 |
| Cayman2015 | 13176 | Oxamflatin | 10 mg | 6160 |
| Cayman2015 | 13176 | Oxamflatin | 5 mg | 3472 |
| Cayman2015 | 13178 | Salermide | 10 mg | 1064 |
| Cayman2015 | 13178 | Salermide | 100 mg | 7840 |
| Cayman2015 | 13178 | Salermide | 5 mg | 560 |
| Cayman2015 | 13178 | Salermide | 50 mg | 4480 |
| Cayman2015 | 13179 | FKGK 11 | 1 mg | 952 |
| Cayman2015 | 13179 | FKGK 11 | 10 mg | 7056 |
| Cayman2015 | 13179 | FKGK 11 | 5 mg | 4032 |
| Cayman2015 | 13179 | FKGK 11 | 500 μg | 504 |
| Cayman2015 | 13181 | CAY10590 | 1 mg | 406 |
| Cayman2015 | 13181 | CAY10590 | 10 mg | 3248 |
| Cayman2015 | 13181 | CAY10590 | 5 mg | 1834 |
| Cayman2015 | 13181 | CAY10590 | 50 mg | 13202 |
| Cayman2015 | 13183 | CP 80633 | 1 mg | 560 |
| Cayman2015 | 13183 | CP 80633 | 10 mg | 4116 |
| Cayman2015 | 13183 | CP 80633 | 5 mg | 2352 |
| Cayman2015 | 13183 | CP 80633 | 500 μg | 294 |
| Cayman2015 | 13184 | (±)-Equol | 10 mg | 686 |
| Cayman2015 | 13184 | (±)-Equol | 25 mg | 1638 |
| Cayman2015 | 13184 | (±)-Equol | 5 mg | 364 |
| Cayman2015 | 13184 | (±)-Equol | 50 mg | 2912 |
| Cayman2015 | 13185 | 17(S)-HpDoHE | 100 μg | 4634 |
| Cayman2015 | 13185 | 17(S)-HpDoHE | 25 μg | 1288 |
| Cayman2015 | 13185 | 17(S)-HpDoHE | 250 μg | 10304 |
| Cayman2015 | 13185 | 17(S)-HpDoHE | 50 μg | 2450 |
| Cayman2015 | 13186 | (±)-Blebbistatin | 10 mg | 1456 |
| Cayman2015 | 13186 | (±)-Blebbistatin | 25 mg | 3388 |
| Cayman2015 | 13186 | (±)-Blebbistatin | 5 mg | 966 |
| Cayman2015 | 13186 | (±)-Blebbistatin | 50 mg | 6286 |
| Cayman2015 | 13187 | Cardiogenol C (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 13187 | Cardiogenol C (hydrochloride) | 10 mg | 1932 |
| Cayman2015 | 13187 | Cardiogenol C (hydrochloride) | 5 mg | 1582 |
| Cayman2015 | 13187 | Cardiogenol C (hydrochloride) | 50 mg | 7882 |
| Cayman2015 | 13188 | Thrombin (human) | 1 KU | 4592 |
| Cayman2015 | 13188 | Thrombin (human) | 100 U | 574 |
| Cayman2015 | 13188 | Thrombin (human) | 250 U | 1358 |
| Cayman2015 | 13196 | NSC 23766 (hydrochloride) | 1 mg | 742 |
| Cayman2015 | 13196 | NSC 23766 (hydrochloride) | 10 mg | 5936 |
| Cayman2015 | 13196 | NSC 23766 (hydrochloride) | 25 mg | 12992 |
| Cayman2015 | 13196 | NSC 23766 (hydrochloride) | 5 mg | 3346 |
| Cayman2015 | 13197 | DAPT | 10 mg | 1862 |
| Cayman2015 | 13197 | DAPT | 25 mg | 4410 |
| Cayman2015 | 13197 | DAPT | 5 mg | 980 |
| Cayman2015 | 13197 | DAPT | 50 mg | 7840 |
| Cayman2015 | 13198 | PP2 | 1 mg | 308 |
| Cayman2015 | 13198 | PP2 | 10 mg | 1848 |
| Cayman2015 | 13198 | PP2 | 25 mg | 3472 |
| Cayman2015 | 13198 | PP2 | 5 mg | 1232 |
| Cayman2015 | 13199 | cis-trismethoxy Resveratrol | 10 mg | 168 |
| Cayman2015 | 13199 | cis-trismethoxy Resveratrol | 100 mg | 1344 |
| Cayman2015 | 13199 | cis-trismethoxy Resveratrol | 50 mg | 756 |
| Cayman2015 | 13199 | cis-trismethoxy Resveratrol | 500 mg | 5880 |
| Cayman2015 | 13200 | G-418 Sulfate | 1 g | 490 |
| Cayman2015 | 13200 | G-418 Sulfate | 5 g | 2282 |
| Cayman2015 | 13202 | Daidzin | 10 mg | 742 |
| Cayman2015 | 13202 | Daidzin | 100 mg | 5488 |
| Cayman2015 | 13202 | Daidzin | 5 mg | 392 |
| Cayman2015 | 13202 | Daidzin | 50 mg | 3136 |
| Cayman2015 | 13203 | Agomelatine | 10 mg | 1624 |
| Cayman2015 | 13203 | Agomelatine | 100 mg | 11956 |
| Cayman2015 | 13203 | Agomelatine | 5 mg | 854 |
| Cayman2015 | 13203 | Agomelatine | 50 mg | 6832 |
| Cayman2015 | 13204 | Robotnikinin | 1 mg | 3975 |
| Cayman2015 | 13205 | Halopemide | 1 mg | 490 |
| Cayman2015 | 13205 | Halopemide | 10 mg | 2702 |
| Cayman2015 | 13205 | Halopemide | 25 mg | 6132 |
| Cayman2015 | 13205 | Halopemide | 5 mg | 1470 |
| Cayman2015 | 13206 | VU0155069 | 1 mg | 406 |
| Cayman2015 | 13206 | VU0155069 | 10 mg | 2030 |
| Cayman2015 | 13206 | VU0155069 | 25 mg | 4060 |
| Cayman2015 | 13206 | VU0155069 | 5 mg | 1120 |
| Cayman2015 | 13207 | CAY10594 | 1 mg | 560 |
| Cayman2015 | 13207 | CAY10594 | 10 mg | 4480 |
| Cayman2015 | 13207 | CAY10594 | 25 mg | 9800 |
| Cayman2015 | 13207 | CAY10594 | 5 mg | 2520 |
| Cayman2015 | 13208 | Mirin | 10 mg | 770 |
| Cayman2015 | 13208 | Mirin | 100 mg | 5684 |
| Cayman2015 | 13208 | Mirin | 5 mg | 406 |
| Cayman2015 | 13208 | Mirin | 50 mg | 3248 |
| Cayman2015 | 13209 | N-octadecanoyl-L-Homoserine lactone | 10 mg | 798 |
| Cayman2015 | 13209 | N-octadecanoyl-L-Homoserine lactone | 25 mg | 1890 |
| Cayman2015 | 13209 | N-octadecanoyl-L-Homoserine lactone | 5 mg | 420 |
| Cayman2015 | 13209 | N-octadecanoyl-L-Homoserine lactone | 50 mg | 3360 |
| Cayman2015 | 13212 | Pimelic Diphenylamide 106 | 1 mg | 280 |
| Cayman2015 | 13212 | Pimelic Diphenylamide 106 | 10 mg | 1680 |
| Cayman2015 | 13212 | Pimelic Diphenylamide 106 | 25 mg | 3682 |
| Cayman2015 | 13212 | Pimelic Diphenylamide 106 | 5 mg | 910 |
| Cayman2015 | 13213 | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | 1 mg | 322 |
| Cayman2015 | 13213 | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | 10 mg | 2576 |
| Cayman2015 | 13213 | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | 25 mg | 5642 |
| Cayman2015 | 13213 | N-3-oxo-tetradec-7(Z)-enoyl-L-Homoserine lactone | 5 mg | 1456 |
| Cayman2015 | 13216 | (±)-CP 47,497-C8-homolog (exempt preparation) | 10 mg | 1568 |
| Cayman2015 | 13216 | (±)-CP 47,497-C8-homolog (exempt preparation) | 25 mg | 3724 |
| Cayman2015 | 13216 | (±)-CP 47,497-C8-homolog (exempt preparation) | 5 mg | 826 |
| Cayman2015 | 13217 | MF63 | 1 mg | 350 |
| Cayman2015 | 13217 | MF63 | 10 mg | 2282 |
| Cayman2015 | 13217 | MF63 | 5 mg | 1316 |
| Cayman2015 | 13217 | MF63 | 50 mg | 9632 |
| Cayman2015 | 13218 | (-)-CP 47,497 (exempt preparation) | 10 mg | 3136 |
| Cayman2015 | 13218 | (-)-CP 47,497 (exempt preparation) | 25 mg | 6790 |
| Cayman2015 | 13218 | (-)-CP 47,497 (exempt preparation) | 5 mg | 1764 |
| Cayman2015 | 13219 | (+)-CP 47,497 (exempt preparation) | 10 mg | 3136 |
| Cayman2015 | 13219 | (+)-CP 47,497 (exempt preparation) | 25 mg | 6790 |
| Cayman2015 | 13219 | (+)-CP 47,497 (exempt preparation) | 5 mg | 1764 |
| Cayman2015 | 13220 | 3-dodecanoyl-NBD Cholesterol | 1 mg | 1806 |
| Cayman2015 | 13220 | 3-dodecanoyl-NBD Cholesterol | 5 mg | 7616 |
| Cayman2015 | 13220 | 3-dodecanoyl-NBD Cholesterol | 500 μg | 952 |
| Cayman2015 | 13221 | 3-hexanoyl-NBD Cholesterol | 1 mg | 1806 |
| Cayman2015 | 13221 | 3-hexanoyl-NBD Cholesterol | 5 mg | 7616 |
| Cayman2015 | 13221 | 3-hexanoyl-NBD Cholesterol | 500 μg | 952 |
| Cayman2015 | 13222 | 2-Acetyl-5-tetrahydroxybutyl Imidazole | 1 mg | 1358 |
| Cayman2015 | 13222 | 2-Acetyl-5-tetrahydroxybutyl Imidazole | 10 mg | 9996 |
| Cayman2015 | 13222 | 2-Acetyl-5-tetrahydroxybutyl Imidazole | 5 mg | 5712 |
| Cayman2015 | 13222 | 2-Acetyl-5-tetrahydroxybutyl Imidazole | 500 μg | 714 |
| Cayman2015 | 13224 | Neurodazine | 10 mg | 1750 |
| Cayman2015 | 13224 | Neurodazine | 25 mg | 3920 |
| Cayman2015 | 13224 | Neurodazine | 5 mg | 1386 |
| Cayman2015 | 13224 | Neurodazine | 50 mg | 7000 |
| Cayman2015 | 13226 | trans-Zeatin | 10 mg | 308 |
| Cayman2015 | 13226 | trans-Zeatin | 100 mg | 1848 |
| Cayman2015 | 13226 | trans-Zeatin | 250 mg | 3472 |
| Cayman2015 | 13226 | trans-Zeatin | 50 mg | 1232 |
| Cayman2015 | 13227 | Fumonisin B2 | 1 mg | 2366 |
| Cayman2015 | 13227 | Fumonisin B2 | 10 mg | 17444 |
| Cayman2015 | 13227 | Fumonisin B2 | 5 mg | 9968 |
| Cayman2015 | 13227 | Fumonisin B2 | 500 μg | 1246 |
| Cayman2015 | 13228 | thio-m-Toluthioamide | 1 g | 154 |
| Cayman2015 | 13228 | thio-m-Toluthioamide | 5 g | 616 |
| Cayman2015 | 13229 | thio-p-Toluamide | 1 g | 602 |
| Cayman2015 | 13229 | thio-p-Toluamide | 250 mg | 168 |
| Cayman2015 | 13229 | thio-p-Toluamide | 5 g | 2688 |
| Cayman2015 | 13229 | thio-p-Toluamide | 500 mg | 322 |
| Cayman2015 | 13230 | Benzamideoxime | 1 g | 350 |
| Cayman2015 | 13230 | Benzamideoxime | 500 mg | 182 |
| Cayman2015 | 13231 | 4-Methylbenzamide oxime | 1 g | 476 |
| Cayman2015 | 13231 | 4-Methylbenzamide oxime | 500 mg | 252 |
| Cayman2015 | 13232 | ethyl-2,4-dimethyl-Thiazole-5-Carboxylate | 1 g | 924 |
| Cayman2015 | 13232 | ethyl-2,4-dimethyl-Thiazole-5-Carboxylate | 100 mg | 154 |
| Cayman2015 | 13232 | ethyl-2,4-dimethyl-Thiazole-5-Carboxylate | 250 mg | 350 |
| Cayman2015 | 13232 | ethyl-2,4-dimethyl-Thiazole-5-Carboxylate | 500 mg | 616 |
| Cayman2015 | 13233 | 2,4-Dimethylthiazole-5-Carboxylic Acid | 1 g | 924 |
| Cayman2015 | 13233 | 2,4-Dimethylthiazole-5-Carboxylic Acid | 100 mg | 154 |
| Cayman2015 | 13233 | 2,4-Dimethylthiazole-5-Carboxylic Acid | 250 mg | 350 |
| Cayman2015 | 13233 | 2,4-Dimethylthiazole-5-Carboxylic Acid | 500 mg | 616 |
| Cayman2015 | 13237 | Thiamet G | 1 mg | 448 |
| Cayman2015 | 13237 | Thiamet G | 10 mg | 1512 |
| Cayman2015 | 13237 | Thiamet G | 5 mg | 1008 |
| Cayman2015 | 13238 | Sphingosine-1-Phosphate Lyase Fluorogenic Substrate | 1 mg | 4032 |
| Cayman2015 | 13238 | Sphingosine-1-Phosphate Lyase Fluorogenic Substrate | 10 mg | 32256 |
| Cayman2015 | 13238 | Sphingosine-1-Phosphate Lyase Fluorogenic Substrate | 5 mg | 18144 |
| Cayman2015 | 13241 | (±)-CP 55,940 | 10 mg | 1568 |
| Cayman2015 | 13241 | (±)-CP 55,940 | 25 mg | 3724 |
| Cayman2015 | 13241 | (±)-CP 55,940 | 5 mg | 826 |
| Cayman2015 | 13241 | (±)-CP 55,940 | 50 mg | 6608 |
| Cayman2015 | 13242 | 3-Methyladenine | 100 mg | 1260 |
| Cayman2015 | 13242 | 3-Methyladenine | 25 mg | 350 |
| Cayman2015 | 13242 | 3-Methyladenine | 50 mg | 672 |
| Cayman2015 | 13243 | KH7 | 10 mg | 1736 |
| Cayman2015 | 13243 | KH7 | 25 mg | 4102 |
| Cayman2015 | 13243 | KH7 | 5 mg | 910 |
| Cayman2015 | 13243 | KH7 | 50 mg | 7280 |
| Cayman2015 | 13245 | Donepezil | 10 mg | 350 |
| Cayman2015 | 13245 | Donepezil | 100 mg | 2632 |
| Cayman2015 | 13245 | Donepezil | 25 mg | 826 |
| Cayman2015 | 13245 | Donepezil | 50 mg | 1386 |
| Cayman2015 | 13246 | YM 58483 | 1 mg | 378 |
| Cayman2015 | 13246 | YM 58483 | 10 mg | 3024 |
| Cayman2015 | 13246 | YM 58483 | 25 mg | 6622 |
| Cayman2015 | 13246 | YM 58483 | 5 mg | 1708 |
| Cayman2015 | 13248 | L-DOPA | 100 g | 2744 |
| Cayman2015 | 13248 | L-DOPA | 25 g | 882 |
| Cayman2015 | 13248 | L-DOPA | 5 g | 196 |
| Cayman2015 | 13248 | L-DOPA | 50 g | 1568 |
| Cayman2015 | 13250 | (-)-AS 115 | 1 mg | 5264 |
| Cayman2015 | 13250 | (-)-AS 115 | 100 μg | 658 |
| Cayman2015 | 13250 | (-)-AS 115 | 500 μg | 2968 |
| Cayman2015 | 13251 | DEPMPO-biotin | 100 μg | 4340 |
| Cayman2015 | 13251 | DEPMPO-biotin | 25 μg | 1204 |
| Cayman2015 | 13251 | DEPMPO-biotin | 250 μg | 9632 |
| Cayman2015 | 13251 | DEPMPO-biotin | 50 μg | 2282 |
| Cayman2015 | 13252 | Sitagliptin (phosphate) | 1 g | 4060 |
| Cayman2015 | 13252 | Sitagliptin (phosphate) | 100 mg | 686 |
| Cayman2015 | 13252 | Sitagliptin (phosphate) | 250 mg | 1428 |
| Cayman2015 | 13252 | Sitagliptin (phosphate) | 50 mg | 406 |
| Cayman2015 | 13254 | FTY720 phenoxy-biotin | 1 mg | 2912 |
| Cayman2015 | 13254 | FTY720 phenoxy-biotin | 100 μg | 364 |
| Cayman2015 | 13254 | FTY720 phenoxy-biotin | 5 mg | 12740 |
| Cayman2015 | 13254 | FTY720 phenoxy-biotin | 500 μg | 1638 |
| Cayman2015 | 13258 | Tamoxifen | 1 g | 1246 |
| Cayman2015 | 13258 | Tamoxifen | 10 g | 9212 |
| Cayman2015 | 13258 | Tamoxifen | 5 g | 5264 |
| Cayman2015 | 13258 | Tamoxifen | 500 mg | 658 |
| Cayman2015 | 13260 | 6-keto Prostaglandin E1 | 1 mg | 980 |
| Cayman2015 | 13260 | 6-keto Prostaglandin E1 | 10 mg | 7840 |
| Cayman2015 | 13260 | 6-keto Prostaglandin E1 | 5 mg | 4410 |
| Cayman2015 | 13261 | URB447 | 10 mg | 1750 |
| Cayman2015 | 13261 | URB447 | 25 mg | 4158 |
| Cayman2015 | 13261 | URB447 | 5 mg | 924 |
| Cayman2015 | 13261 | URB447 | 50 mg | 7392 |
| Cayman2015 | 13264 | Platencin | 100 μg | 4550 |
| Cayman2015 | 13264 | Platencin | 500 μg | 13650 |
| Cayman2015 | 13265 | 4-hydroxy Nonenal Alkyne | 1 mg | 4816 |
| Cayman2015 | 13265 | 4-hydroxy Nonenal Alkyne | 100 μg | 602 |
| Cayman2015 | 13265 | 4-hydroxy Nonenal Alkyne | 5 mg | 19572 |
| Cayman2015 | 13265 | 4-hydroxy Nonenal Alkyne | 500 μg | 2716 |
| Cayman2015 | 13266 | Palmitic Acid Alkyne | 1 mg | 980 |
| Cayman2015 | 13266 | Palmitic Acid Alkyne | 10 mg | 5460 |
| Cayman2015 | 13266 | Palmitic Acid Alkyne | 5 mg | 3822 |
| Cayman2015 | 13266 | Palmitic Acid Alkyne | 500 μg | 546 |
| Cayman2015 | 13267 | Myristic Acid Alkyne | 1 mg | 4816 |
| Cayman2015 | 13267 | Myristic Acid Alkyne | 100 μg | 602 |
| Cayman2015 | 13267 | Myristic Acid Alkyne | 5 mg | 19572 |
| Cayman2015 | 13267 | Myristic Acid Alkyne | 500 μg | 2716 |
| Cayman2015 | 13269 | Farnesyl Alcohol Azide | 1 mg | 5152 |
| Cayman2015 | 13269 | Farnesyl Alcohol Azide | 100 μg | 644 |
| Cayman2015 | 13269 | Farnesyl Alcohol Azide | 500 μg | 2898 |
| Cayman2015 | 13271 | ZLJ-6 | 1 mg | 434 |
| Cayman2015 | 13271 | ZLJ-6 | 10 mg | 3472 |
| Cayman2015 | 13271 | ZLJ-6 | 25 mg | 7602 |
| Cayman2015 | 13271 | ZLJ-6 | 5 mg | 1960 |
| Cayman2015 | 13279 | PF-3845 | 1 mg | 308 |
| Cayman2015 | 13279 | PF-3845 | 10 mg | 2464 |
| Cayman2015 | 13279 | PF-3845 | 25 mg | 5390 |
| Cayman2015 | 13279 | PF-3845 | 5 mg | 1386 |
| Cayman2015 | 13280 | Panobinostat | 10 mg | 1036 |
| Cayman2015 | 13280 | Panobinostat | 25 mg | 2058 |
| Cayman2015 | 13280 | Panobinostat | 5 mg | 686 |
| Cayman2015 | 13280 | Panobinostat | 50 mg | 3094 |
| Cayman2015 | 13281 | CAY10598 | 1 mg | 2044 |
| Cayman2015 | 13281 | CAY10598 | 10 mg | 15092 |
| Cayman2015 | 13281 | CAY10598 | 5 mg | 8624 |
| Cayman2015 | 13281 | CAY10598 | 500 μg | 1078 |
| Cayman2015 | 13282 | CAY10599 | 1 mg | 644 |
| Cayman2015 | 13282 | CAY10599 | 10 mg | 5152 |
| Cayman2015 | 13282 | CAY10599 | 25 mg | 11270 |
| Cayman2015 | 13282 | CAY10599 | 5 mg | 2898 |
| Cayman2015 | 13284 | MS-275 | 1 mg | 224 |
| Cayman2015 | 13284 | MS-275 | 10 mg | 1344 |
| Cayman2015 | 13284 | MS-275 | 25 mg | 2520 |
| Cayman2015 | 13284 | MS-275 | 5 mg | 896 |
| Cayman2015 | 13285 | Cannabidiol dimethyl ether | 1 mg | 350 |
| Cayman2015 | 13285 | Cannabidiol dimethyl ether | 10 mg | 2800 |
| Cayman2015 | 13285 | Cannabidiol dimethyl ether | 5 mg | 1582 |
| Cayman2015 | 13285 | Cannabidiol dimethyl ether | 50 mg | 12250 |
| Cayman2015 | 13287 | FK-866 | 10 mg | 2212 |
| Cayman2015 | 13287 | FK-866 | 25 mg | 4928 |
| Cayman2015 | 13287 | FK-866 | 5 mg | 1232 |
| Cayman2015 | 13287 | FK-866 | 50 mg | 7392 |
| Cayman2015 | 13288 | Itraconazole | 100 mg | 1162 |
| Cayman2015 | 13288 | Itraconazole | 25 mg | 322 |
| Cayman2015 | 13288 | Itraconazole | 250 mg | 2576 |
| Cayman2015 | 13288 | Itraconazole | 50 mg | 616 |
| Cayman2015 | 13289 | CB-86 | 1 mg | 406 |
| Cayman2015 | 13289 | CB-86 | 10 mg | 3248 |
| Cayman2015 | 13289 | CB-86 | 5 mg | 1834 |
| Cayman2015 | 13289 | CB-86 | 50 mg | 13720 |
| Cayman2015 | 13291 | CAY10616 | 1 mg | 294 |
| Cayman2015 | 13291 | CAY10616 | 10 mg | 2352 |
| Cayman2015 | 13291 | CAY10616 | 25 mg | 5152 |
| Cayman2015 | 13291 | CAY10616 | 5 mg | 1330 |
| Cayman2015 | 13293 | Rhapontigenin | 1 mg | 1008 |
| Cayman2015 | 13293 | Rhapontigenin | 10 mg | 8064 |
| Cayman2015 | 13293 | Rhapontigenin | 25 mg | 17640 |
| Cayman2015 | 13293 | Rhapontigenin | 5 mg | 4536 |
| Cayman2015 | 13294 | Pyrrophenone | 1 mg | 2478 |
| Cayman2015 | 13294 | Pyrrophenone | 10 mg | 18228 |
| Cayman2015 | 13294 | Pyrrophenone | 5 mg | 10416 |
| Cayman2015 | 13294 | Pyrrophenone | 500 μg | 1302 |
| Cayman2015 | 13295 | HNHA | 10 mg | 4340 |
| Cayman2015 | 13295 | HNHA | 25 mg | 10276 |
| Cayman2015 | 13295 | HNHA | 5 mg | 2282 |
| Cayman2015 | 13297 | AG-126 | 1 mg | 350 |
| Cayman2015 | 13297 | AG-126 | 10 mg | 1932 |
| Cayman2015 | 13297 | AG-126 | 25 mg | 4382 |
| Cayman2015 | 13297 | AG-126 | 5 mg | 1050 |
| Cayman2015 | 13298 | Bisindolylmaleimide I | 10 mg | 1834 |
| Cayman2015 | 13298 | Bisindolylmaleimide I | 25 mg | 4354 |
| Cayman2015 | 13298 | Bisindolylmaleimide I | 5 mg | 966 |
| Cayman2015 | 13298 | Bisindolylmaleimide I | 50 mg | 7728 |
| Cayman2015 | 13299 | Bisindolylmaleimide IV | 1 mg | 574 |
| Cayman2015 | 13299 | Bisindolylmaleimide IV | 10 mg | 4592 |
| Cayman2015 | 13299 | Bisindolylmaleimide IV | 25 mg | 10052 |
| Cayman2015 | 13299 | Bisindolylmaleimide IV | 5 mg | 2590 |
| Cayman2015 | 13300 | Bisindolylmaleimide V | 1 mg | 714 |
| Cayman2015 | 13300 | Bisindolylmaleimide V | 10 mg | 5712 |
| Cayman2015 | 13300 | Bisindolylmaleimide V | 25 mg | 12502 |
| Cayman2015 | 13300 | Bisindolylmaleimide V | 5 mg | 3220 |
| Cayman2015 | 13302 | RG-108 | 10 mg | 1302 |
| Cayman2015 | 13302 | RG-108 | 100 mg | 9604 |
| Cayman2015 | 13302 | RG-108 | 5 mg | 686 |
| Cayman2015 | 13302 | RG-108 | 50 mg | 5488 |
| Cayman2015 | 13303 | NSC 663284 | 1 mg | 294 |
| Cayman2015 | 13303 | NSC 663284 | 10 mg | 2352 |
| Cayman2015 | 13303 | NSC 663284 | 25 mg | 5152 |
| Cayman2015 | 13303 | NSC 663284 | 5 mg | 1330 |
| Cayman2015 | 13304 | Biotin-XX hydrazide | 10 mg | 644 |
| Cayman2015 | 13304 | Biotin-XX hydrazide | 25 mg | 1512 |
| Cayman2015 | 13304 | Biotin-XX hydrazide | 5 mg | 336 |
| Cayman2015 | 13305 | D 4476 | 1 mg | 266 |
| Cayman2015 | 13305 | D 4476 | 10 mg | 2128 |
| Cayman2015 | 13305 | D 4476 | 5 mg | 1204 |
| Cayman2015 | 13305 | D 4476 | 50 mg | 9310 |
| Cayman2015 | 13307 | D609 (potassium salt) | 1 mg | 406 |
| Cayman2015 | 13307 | D609 (potassium salt) | 10 mg | 1624 |
| Cayman2015 | 13307 | D609 (potassium salt) | 25 mg | 3556 |
| Cayman2015 | 13307 | D609 (potassium salt) | 5 mg | 910 |
| Cayman2015 | 13308 | NU 7026 | 10 mg | 1736 |
| Cayman2015 | 13308 | NU 7026 | 25 mg | 4102 |
| Cayman2015 | 13308 | NU 7026 | 5 mg | 910 |
| Cayman2015 | 13308 | NU 7026 | 50 mg | 7280 |
| Cayman2015 | 13311 | G? 6983 | 1 mg | 490 |
| Cayman2015 | 13311 | G? 6983 | 10 mg | 2520 |
| Cayman2015 | 13311 | G? 6983 | 5 mg | 1680 |
| Cayman2015 | 13312 | H-9 (hydrochloride) | 10 mg | 560 |
| Cayman2015 | 13312 | H-9 (hydrochloride) | 25 mg | 1330 |
| Cayman2015 | 13312 | H-9 (hydrochloride) | 5 mg | 294 |
| Cayman2015 | 13312 | H-9 (hydrochloride) | 50 mg | 2352 |
| Cayman2015 | 13314 | Indirubin-3'-monoxime | 1 mg | 532 |
| Cayman2015 | 13314 | Indirubin-3'-monoxime | 10 mg | 1862 |
| Cayman2015 | 13314 | Indirubin-3'-monoxime | 5 mg | 1064 |
| Cayman2015 | 13314 | Indirubin-3'-monoxime | 50 mg | 7980 |
| Cayman2015 | 13315 | Biotin-NHS | 1 g | 6384 |
| Cayman2015 | 13315 | Biotin-NHS | 100 mg | 798 |
| Cayman2015 | 13315 | Biotin-NHS | 250 mg | 1890 |
| Cayman2015 | 13315 | Biotin-NHS | 500 mg | 3598 |
| Cayman2015 | 13316 | Biotin-X-NHS | 1 g | 10640 |
| Cayman2015 | 13316 | Biotin-X-NHS | 100 mg | 1330 |
| Cayman2015 | 13316 | Biotin-X-NHS | 250 mg | 3164 |
| Cayman2015 | 13316 | Biotin-X-NHS | 500 mg | 5992 |
| Cayman2015 | 13317 | NU 6102 | 1 mg | 495 |
| Cayman2015 | 13317 | NU 6102 | 5 mg | 2235 |
| Cayman2015 | 13318 | KN-62 | 1 mg | 588 |
| Cayman2015 | 13318 | KN-62 | 10 mg | 4704 |
| Cayman2015 | 13318 | KN-62 | 25 mg | 10290 |
| Cayman2015 | 13318 | KN-62 | 5 mg | 2646 |
| Cayman2015 | 13319 | KN-93 | 1 mg | 1204 |
| Cayman2015 | 13319 | KN-93 | 10 mg | 9632 |
| Cayman2015 | 13319 | KN-93 | 5 mg | 5418 |
| Cayman2015 | 13320 | MCI-186 | 100 g | 280 |
| Cayman2015 | 13320 | MCI-186 | 5 g | 238 |
| Cayman2015 | 13320 | MCI-186 | 500 g | 476 |
| Cayman2015 | 13321 | ARP 100 | 1 mg | 308 |
| Cayman2015 | 13321 | ARP 100 | 10 mg | 2128 |
| Cayman2015 | 13321 | ARP 100 | 5 mg | 1162 |
| Cayman2015 | 13322 | CGP 57380 | 1 mg | 490 |
| Cayman2015 | 13322 | CGP 57380 | 10 mg | 1666 |
| Cayman2015 | 13322 | CGP 57380 | 25 mg | 3430 |
| Cayman2015 | 13322 | CGP 57380 | 5 mg | 1232 |
| Cayman2015 | 13323 | IM-54 | 1 mg | 336 |
| Cayman2015 | 13323 | IM-54 | 10 mg | 2688 |
| Cayman2015 | 13323 | IM-54 | 25 mg | 5880 |
| Cayman2015 | 13323 | IM-54 | 5 mg | 1512 |
| Cayman2015 | 13324 | NF449 (sodium salt) | 10 mg | 1750 |
| Cayman2015 | 13324 | NF449 (sodium salt) | 50 mg | 7616 |
| Cayman2015 | 13325 | Iso-Olomoucine | 10 mg | 1148 |
| Cayman2015 | 13325 | Iso-Olomoucine | 25 mg | 2716 |
| Cayman2015 | 13325 | Iso-Olomoucine | 5 mg | 602 |
| Cayman2015 | 13325 | Iso-Olomoucine | 50 mg | 4816 |
| Cayman2015 | 13326 | Pifithrin-α | 10 mg | 1148 |
| Cayman2015 | 13326 | Pifithrin-α | 25 mg | 2674 |
| Cayman2015 | 13326 | Pifithrin-α | 5 mg | 714 |
| Cayman2015 | 13326 | Pifithrin-α | 50 mg | 4284 |
| Cayman2015 | 13327 | PPM-18 | 1 mg | 196 |
| Cayman2015 | 13327 | PPM-18 | 10 mg | 1568 |
| Cayman2015 | 13327 | PPM-18 | 25 mg | 3430 |
| Cayman2015 | 13327 | PPM-18 | 5 mg | 882 |
| Cayman2015 | 13330 | 1-NM-PP1 | 1 mg | 1204 |
| Cayman2015 | 13330 | 1-NM-PP1 | 10 mg | 9632 |
| Cayman2015 | 13330 | 1-NM-PP1 | 25 mg | 21070 |
| Cayman2015 | 13330 | 1-NM-PP1 | 5 mg | 5418 |
| Cayman2015 | 13331 | bpV(phen) (potassium hydrate) | 25 mg | 2925 |
| Cayman2015 | 13331 | bpV(phen) (potassium hydrate) | 5 mg | 975 |
| Cayman2015 | 13332 | (S)-Glycyl-H-1152 (hydrochloride) | 1 mg | 2002 |
| Cayman2015 | 13332 | (S)-Glycyl-H-1152 (hydrochloride) | 10 mg | 14700 |
| Cayman2015 | 13332 | (S)-Glycyl-H-1152 (hydrochloride) | 5 mg | 8400 |
| Cayman2015 | 13332 | (S)-Glycyl-H-1152 (hydrochloride) | 500 μg | 1050 |
| Cayman2015 | 13333 | Bisindolylmaleimide VIII (acetate) | 1 mg | 560 |
| Cayman2015 | 13333 | Bisindolylmaleimide VIII (acetate) | 10 mg | 3920 |
| Cayman2015 | 13333 | Bisindolylmaleimide VIII (acetate) | 5 mg | 2086 |
| Cayman2015 | 13334 | Bisindolylmaleimide IX (mesylate) | 1 mg | 490 |
| Cayman2015 | 13334 | Bisindolylmaleimide IX (mesylate) | 10 mg | 2786 |
| Cayman2015 | 13334 | Bisindolylmaleimide IX (mesylate) | 5 mg | 1890 |
| Cayman2015 | 13336 | SB 225002 | 10 mg | 1750 |
| Cayman2015 | 13336 | SB 225002 | 25 mg | 4158 |
| Cayman2015 | 13336 | SB 225002 | 5 mg | 924 |
| Cayman2015 | 13336 | SB 225002 | 50 mg | 7392 |
| Cayman2015 | 13337 | ST638 | 1 mg | 420 |
| Cayman2015 | 13337 | ST638 | 10 mg | 3360 |
| Cayman2015 | 13337 | ST638 | 25 mg | 7350 |
| Cayman2015 | 13337 | ST638 | 5 mg | 1890 |
| Cayman2015 | 13338 | SU 6656 | 1 mg | 294 |
| Cayman2015 | 13338 | SU 6656 | 10 mg | 2352 |
| Cayman2015 | 13338 | SU 6656 | 25 mg | 5152 |
| Cayman2015 | 13338 | SU 6656 | 5 mg | 1330 |
| Cayman2015 | 13339 | SQ 22,536 | 10 mg | 1302 |
| Cayman2015 | 13339 | SQ 22,536 | 25 mg | 3094 |
| Cayman2015 | 13339 | SQ 22,536 | 5 mg | 686 |
| Cayman2015 | 13339 | SQ 22,536 | 50 mg | 5488 |
| Cayman2015 | 13340 | TPEN | 10 mg | 168 |
| Cayman2015 | 13340 | TPEN | 100 mg | 1344 |
| Cayman2015 | 13340 | TPEN | 25 mg | 406 |
| Cayman2015 | 13340 | TPEN | 50 mg | 756 |
| Cayman2015 | 13341 | LY364947 | 10 mg | 1974 |
| Cayman2015 | 13341 | LY364947 | 25 mg | 4662 |
| Cayman2015 | 13341 | LY364947 | 5 mg | 1036 |
| Cayman2015 | 13341 | LY364947 | 50 mg | 8288 |
| Cayman2015 | 13344 | SB 203580 (hydrochloride) | 10 mg | 2394 |
| Cayman2015 | 13344 | SB 203580 (hydrochloride) | 25 mg | 5670 |
| Cayman2015 | 13344 | SB 203580 (hydrochloride) | 5 mg | 1260 |
| Cayman2015 | 13344 | SB 203580 (hydrochloride) | 50 mg | 10080 |
| Cayman2015 | 13345 | GYY 4137 | 10 mg | 658 |
| Cayman2015 | 13345 | GYY 4137 | 100 mg | 5264 |
| Cayman2015 | 13345 | GYY 4137 | 25 mg | 1568 |
| Cayman2015 | 13345 | GYY 4137 | 50 mg | 2968 |
| Cayman2015 | 13346 | Rapamycin | 1 mg | 406 |
| Cayman2015 | 13346 | Rapamycin | 10 mg | 1568 |
| Cayman2015 | 13346 | Rapamycin | 25 mg | 3710 |
| Cayman2015 | 13346 | Rapamycin | 5 mg | 966 |
| Cayman2015 | 13347 | IBMX | 100 mg | 406 |
| Cayman2015 | 13347 | IBMX | 250 mg | 896 |
| Cayman2015 | 13347 | IBMX | 50 mg | 224 |
| Cayman2015 | 13347 | IBMX | 500 mg | 1344 |
| Cayman2015 | 13351 | Myristic Acid | 1 g | 140 |
| Cayman2015 | 13351 | Myristic Acid | 10 g | 1120 |
| Cayman2015 | 13351 | Myristic Acid | 5 g | 630 |
| Cayman2015 | 13352 | EHNA (hydrochloride) | 10 mg | 672 |
| Cayman2015 | 13352 | EHNA (hydrochloride) | 25 mg | 1582 |
| Cayman2015 | 13352 | EHNA (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 13353 | Lignoceric Acid | 100 mg | 322 |
| Cayman2015 | 13353 | Lignoceric Acid | 250 mg | 728 |
| Cayman2015 | 13353 | Lignoceric Acid | 50 mg | 182 |
| Cayman2015 | 13353 | Lignoceric Acid | 500 mg | 1092 |
| Cayman2015 | 13354 | Hexacosanoic Acid | 100 mg | 1302 |
| Cayman2015 | 13354 | Hexacosanoic Acid | 250 mg | 3094 |
| Cayman2015 | 13354 | Hexacosanoic Acid | 50 mg | 686 |
| Cayman2015 | 13355 | Geldanamycin | 1 mg | 630 |
| Cayman2015 | 13355 | Geldanamycin | 10 mg | 2352 |
| Cayman2015 | 13355 | Geldanamycin | 5 mg | 1372 |
| Cayman2015 | 13357 | Milrinone | 10 mg | 1736 |
| Cayman2015 | 13357 | Milrinone | 100 mg | 12740 |
| Cayman2015 | 13357 | Milrinone | 5 mg | 910 |
| Cayman2015 | 13357 | Milrinone | 50 mg | 7280 |
| Cayman2015 | 13358 | CAY10608 | 1 mg | 420 |
| Cayman2015 | 13358 | CAY10608 | 10 mg | 3360 |
| Cayman2015 | 13358 | CAY10608 | 25 mg | 7350 |
| Cayman2015 | 13358 | CAY10608 | 5 mg | 1890 |
| Cayman2015 | 13360 | 8-iso Prostaglandin E1 | 1 mg | 980 |
| Cayman2015 | 13360 | 8-iso Prostaglandin E1 | 10 mg | 7252 |
| Cayman2015 | 13360 | 8-iso Prostaglandin E1 | 5 mg | 4144 |
| Cayman2015 | 13360 | 8-iso Prostaglandin E1 | 500 μg | 518 |
| Cayman2015 | 13363 | tetranor-PGJM | 100 μg | 6048 |
| Cayman2015 | 13363 | tetranor-PGJM | 25 μg | 1680 |
| Cayman2015 | 13363 | tetranor-PGJM | 50 μg | 3192 |
| Cayman2015 | 13365 | Programmed Cell Death Protein 4 (C-term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 13368 | Piroxicam | 1 g | 406 |
| Cayman2015 | 13368 | Piroxicam | 10 g | 2940 |
| Cayman2015 | 13368 | Piroxicam | 5 g | 1680 |
| Cayman2015 | 13368 | Piroxicam | 500 mg | 210 |
| Cayman2015 | 13369 | tetranor-PGAM | 100 μg | 5040 |
| Cayman2015 | 13369 | tetranor-PGAM | 25 μg | 1400 |
| Cayman2015 | 13369 | tetranor-PGAM | 50 μg | 2660 |
| Cayman2015 | 13370 | Halofuginone (hydrochloride) | 1 mg | 2492 |
| Cayman2015 | 13370 | Halofuginone (hydrochloride) | 5 mg | 5544 |
| Cayman2015 | 13370 | Halofuginone (hydrochloride) | 500 μg | 1386 |
| Cayman2015 | 13371 | CAY10621 | 1 mg | 294 |
| Cayman2015 | 13371 | CAY10621 | 10 mg | 2352 |
| Cayman2015 | 13371 | CAY10621 | 25 mg | 5152 |
| Cayman2015 | 13371 | CAY10621 | 5 mg | 1330 |
| Cayman2015 | 13373 | 2',3',5'-triacetyl-5-Azacytidine | 10 mg | 1302 |
| Cayman2015 | 13373 | 2',3',5'-triacetyl-5-Azacytidine | 100 mg | 9604 |
| Cayman2015 | 13373 | 2',3',5'-triacetyl-5-Azacytidine | 5 mg | 686 |
| Cayman2015 | 13373 | 2',3',5'-triacetyl-5-Azacytidine | 50 mg | 5488 |
| Cayman2015 | 13375 | Atrazine | 100 mg | 196 |
| Cayman2015 | 13375 | Atrazine | 250 mg | 462 |
| Cayman2015 | 13375 | Atrazine | 500 mg | 882 |
| Cayman2015 | 13379 | 5-bromo-3-phenyl Salicylic Acid | 1 mg | 602 |
| Cayman2015 | 13379 | 5-bromo-3-phenyl Salicylic Acid | 10 mg | 4816 |
| Cayman2015 | 13379 | 5-bromo-3-phenyl Salicylic Acid | 25 mg | 10542 |
| Cayman2015 | 13379 | 5-bromo-3-phenyl Salicylic Acid | 5 mg | 2716 |
| Cayman2015 | 13381 | CAY10606 | 1 mg | 686 |
| Cayman2015 | 13381 | CAY10606 | 10 mg | 5488 |
| Cayman2015 | 13381 | CAY10606 | 5 mg | 3094 |
| Cayman2015 | 13382 | DAz-2 | 1 mg | 686 |
| Cayman2015 | 13382 | DAz-2 | 10 mg | 4452 |
| Cayman2015 | 13382 | DAz-2 | 5 mg | 2366 |
| Cayman2015 | 13384 | 5-(2-Aminopyridyl)amide oxime | 1 g | 9016 |
| Cayman2015 | 13384 | 5-(2-Aminopyridyl)amide oxime | 100 mg | 1218 |
| Cayman2015 | 13384 | 5-(2-Aminopyridyl)amide oxime | 50 mg | 644 |
| Cayman2015 | 13384 | 5-(2-Aminopyridyl)amide oxime | 500 mg | 5152 |
| Cayman2015 | 13386 | 2-methyl-4-phenyl Thiazole | 1 g | 4032 |
| Cayman2015 | 13386 | 2-methyl-4-phenyl Thiazole | 100 mg | 504 |
| Cayman2015 | 13386 | 2-methyl-4-phenyl Thiazole | 250 mg | 1204 |
| Cayman2015 | 13386 | 2-methyl-4-phenyl Thiazole | 500 mg | 2268 |
| Cayman2015 | 13387 | ethyl-2-amino-4-phenyl Thiophene-3-Carboxylate | 1 g | 924 |
| Cayman2015 | 13387 | ethyl-2-amino-4-phenyl Thiophene-3-Carboxylate | 100 mg | 154 |
| Cayman2015 | 13387 | ethyl-2-amino-4-phenyl Thiophene-3-Carboxylate | 250 mg | 350 |
| Cayman2015 | 13387 | ethyl-2-amino-4-phenyl Thiophene-3-Carboxylate | 500 mg | 616 |
| Cayman2015 | 13388 | 2-amino-4-phenyl Thiazole | 1 g | 448 |
| Cayman2015 | 13388 | 2-amino-4-phenyl Thiazole | 10 g | 3332 |
| Cayman2015 | 13388 | 2-amino-4-phenyl Thiazole | 5 g | 1904 |
| Cayman2015 | 13388 | 2-amino-4-phenyl Thiazole | 500 mg | 238 |
| Cayman2015 | 13389 | 2-amino Pyridyl-5-thioamide | 1 g | 4032 |
| Cayman2015 | 13389 | 2-amino Pyridyl-5-thioamide | 100 mg | 504 |
| Cayman2015 | 13389 | 2-amino Pyridyl-5-thioamide | 250 mg | 1204 |
| Cayman2015 | 13389 | 2-amino Pyridyl-5-thioamide | 500 mg | 2268 |
| Cayman2015 | 13390 | N-methyl Leukotriene C4 | 100 μg | 6748 |
| Cayman2015 | 13390 | N-methyl Leukotriene C4 | 25 μg | 1876 |
| Cayman2015 | 13390 | N-methyl Leukotriene C4 | 50 μg | 3570 |
| Cayman2015 | 13391 | Goat Anti-Chicken IgY:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13392 | Goat Anti-Human IgG:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13393 | Goat Anti-Llama IgG:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13394 | Goat Anti-Mouse IgG:SureLight? APC | 1 ea | 1425 |
| Cayman2015 | 13395 | Goat Anti-Mouse IgG1:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13396 | Goat Anti-Mouse IgG2a:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13397 | Goat Anti-Mouse IgG2b:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13398 | Goat Anti-Mouse IgG3:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13399 | Goat Anti-Rabbit IgG:SureLight? APC | 1 ea | 1425 |
| Cayman2015 | 13400 | Goat Anti-GST IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13401 | Mouse IgG1 Isotype Control:SureLight? APC | 1 ea | 2835 |
| Cayman2015 | 13403 | Mouse Anti-c-myc IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 13404 | Mouse Anti-DYKDDDDK IgG:SureLight? APC | 1 mg | 6465 |
| Cayman2015 | 13404 | Mouse Anti-DYKDDDDK IgG:SureLight? APC | 100 μg | 5115 |
| Cayman2015 | 13406 | Rabbit Anti-HA tag IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13407 | Rabbit Anti-V5 tag IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13408 | Rabbit Anti-S tag IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13409 | Rabbit Anti-T7 IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13410 | Streptavidin:SureLight? APC | 1 ea | 4575 |
| Cayman2015 | 13411 | SL-APC Conjugation Kit | 1 ea | 5985 |
| Cayman2015 | 13412 | SureLight? APC Conjugation Kit for 2 mg IgG | 1 ea | 9840 |
| Cayman2015 | 13413 | Goat Anti-Chicken IgY:RPE | 1 ea | 2835 |
| Cayman2015 | 13414 | Goat Anti-Human IgG Fcγ:SureLight? RPE | 1 ea | 2835 |
| Cayman2015 | 13415 | Goat Anti-Llama IgG:RPE | 1 ea | 2835 |
| Cayman2015 | 13416 | Goat Anti-Mouse IgG (H+L):RPE | 1 ea | 2835 |
| Cayman2015 | 13417 | Goat Anti-Mouse IgG1:RPE | 1 ea | 2835 |
| Cayman2015 | 13418 | Goat Anti-Mouse IgG2a:RPE | 1 ea | 2835 |
| Cayman2015 | 13419 | Goat Anti-Mouse IgG2b:RPE | 1 ea | 2835 |
| Cayman2015 | 13420 | Goat Anti-Mouse IgG3:RPE | 1 ea | 2835 |
| Cayman2015 | 13421 | Goat Anti-Rabbit IgG:RPE | 1 ea | 1425 |
| Cayman2015 | 13422 | Goat Anti-GST IgG:RPE | 1 ea | 4710 |
| Cayman2015 | 13423 | Mouse IgG1 Isotype Control:RPE | 1 ea | 2835 |
| Cayman2015 | 13424 | Rabbit IgG Negative Control:RPE | 1 ea | 2835 |
| Cayman2015 | 13425 | Mouse Anti-6His IgG:RPE | 1 ea | 4710 |
| Cayman2015 | 13426 | Mouse Anti-c-myc:RPE | 1 ea | 4710 |
| Cayman2015 | 13427 | Mouse Anti-DYKDDDDK IgG:RPE | 1 ea | 4710 |
| Cayman2015 | 13429 | Mouse Anti-HA:RPE | 1 ea | 4710 |
| Cayman2015 | 13430 | Rabbit Anti-V5 tag IgG:SureLight? RPE | 1 ea | 4710 |
| Cayman2015 | 13431 | Rabbit Anti-HA:RPE | 1 ea | 4710 |
| Cayman2015 | 13432 | Rabbit Anti-S tag:RPE | 1 ea | 4710 |
| Cayman2015 | 13433 | Rabbit Anti-T7 IgG:RPE | 1 ea | 4710 |
| Cayman2015 | 13434 | Streptavidin:RPE | 1 ea | 3390 |
| Cayman2015 | 13435 | Streptavidin:RPE (liquid) | 1 ea | 3390 |
| Cayman2015 | 13436 | RPE Conjugation Kit | 1 ea | 5985 |
| Cayman2015 | 13444 | Goat Anti-Mouse IgG:SureLight? P3 | 1 ea | 4575 |
| Cayman2015 | 13448 | Goat Anti-GST IgG:SureLight? P3 | 1 ea | 4710 |
| Cayman2015 | 13449 | Mouse Anti-6HIS IgG:SureLight? P3 | 1 ea | 4710 |
| Cayman2015 | 13450 | 11β-Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13450 | 11β-Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13450 | 11β-Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13452 | AM3102 | 10 mg | 938 |
| Cayman2015 | 13452 | AM3102 | 100 mg | 6860 |
| Cayman2015 | 13452 | AM3102 | 5 mg | 490 |
| Cayman2015 | 13452 | AM3102 | 50 mg | 3920 |
| Cayman2015 | 13453 | LH 21 | 1 mg | 658 |
| Cayman2015 | 13453 | LH 21 | 10 mg | 5264 |
| Cayman2015 | 13453 | LH 21 | 5 mg | 2968 |
| Cayman2015 | 13454 | PGDM | 100 μg | 7252 |
| Cayman2015 | 13454 | PGDM | 25 μg | 2016 |
| Cayman2015 | 13454 | PGDM | 50 μg | 3836 |
| Cayman2015 | 13455 | Mouse anti-c-myc IgG:SureLight? P3 | 1 ea | 4710 |
| Cayman2015 | 13456 | Mouse Anti-DYKDDDDK IgG:SureLight? P3 | 1 ea | 4710 |
| Cayman2015 | 13457 | Streptavidin:SureLight? P3 | 1 ea | 3390 |
| Cayman2015 | 13459 | Goat Anti-Mouse (H+L):Alkaline Phosphatase | 1 ea | 2130 |
| Cayman2015 | 13460 | Goat Anti-Rabbit (H+L):Alkaline Phosphatase | 1 ea | 2130 |
| Cayman2015 | 13461 | Goat Anti-GST IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13462 | Mouse Anti-6HIS IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13463 | Mouse Anti-c-myc IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13464 | Mouse Anti-DYKDDDDK IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13465 | Mouse Anti-HA IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13466 | Rabbit Anti-S tag IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13467 | Rabbit Anti-T7 IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13468 | Rabbit Anti-V5 tag IgG:Alkaline Phosphatase | 1 ea | 4710 |
| Cayman2015 | 13469 | Mouse Anti-c-myc IgG:Biotin | 1 ea | 4710 |
| Cayman2015 | 13470 | Mouse Anti-HA IgG:Biotin | 1 ea | 4710 |
| Cayman2015 | 13471 | Rabbit Anti-S tag IgG:Biotin | 1 ea | 4710 |
| Cayman2015 | 13472 | Rabbit Anti-T7 IgG:Biotin | 1 ea | 4710 |
| Cayman2015 | 13473 | Rabbit Anti-V5 tag IgG:Biotin | 1 ea | 4710 |
| Cayman2015 | 13477 | SIRT7 Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13479 | DNA Methyltransferase 1 Monoclonal Antibody (Clone 60B1220.1) | 1 ea | 4242 |
| Cayman2015 | 13482 | DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B814.1) | 1 ea | 4242 |
| Cayman2015 | 13483 | DNA Methyltransferase 3a Monoclonal Antibody - Biotinylated (Clone 64B814.1) | 1 ea | 4326 |
| Cayman2015 | 13484 | DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B1446) | 1 ea | 4242 |
| Cayman2015 | 13485 | DNA Methyltransferase 3b Monoclonal Antibody (Clone 52A1018) | 1 ea | 4242 |
| Cayman2015 | 13486 | LSD1 Polyclonal Antibody (aa 450-500) | 1 ea | 3528 |
| Cayman2015 | 13488 | S1P2 Polyclonal Antibody | 1 ea | 3864 |
| Cayman2015 | 13489 | S1P4 Polyclonal Antibody | 1 ea | 3864 |
| Cayman2015 | 13490 | S1P5 Polyclonal Antibody | 1 ea | 3990 |
| Cayman2015 | 13491 | HDAC1 Polyclonal Antibody | 1 ea | 3528 |
| Cayman2015 | 13492 | Androgen Receptor (Phospho-Ser210,213) Monoclonal Antibody (Clone 156C135.2) | 1 ea | 4130 |
| Cayman2015 | 13493 | HDAC3 Polyclonal Antibody | 1 ea | 3528 |
| Cayman2015 | 13494 | HDAC4 Polyclonal Antibody | 1 ea | 3962 |
| Cayman2015 | 13495 | ARAP2 Polyclonal Antibody | 1 ea | 3864 |
| Cayman2015 | 13496 | AROS Polyclonal Antibody (aa 1-50) | 1 ea | 3864 |
| Cayman2015 | 13497 | BRD4/HUNK1 Polyclonal Antibody | 1 ea | 3542 |
| Cayman2015 | 13499 | HDAC6 Polyclonal Antibody | 1 ea | 3962 |
| Cayman2015 | 13500 | HDAC7 (Phospho-Ser155) Polyclonal Antibody | 1 ea | 4158 |
| Cayman2015 | 13502 | Bnc 1 Polyclonal Antibody | 1 ea | 3864 |
| Cayman2015 | 13504 | HDAC11 Polyclonal Antibody | 1 ea | 3990 |
| Cayman2015 | 13510 | 11-deoxy Prostaglandin E1 | 1 mg | 686 |
| Cayman2015 | 13510 | 11-deoxy Prostaglandin E1 | 10 mg | 5096 |
| Cayman2015 | 13510 | 11-deoxy Prostaglandin E1 | 5 mg | 2912 |
| Cayman2015 | 13510 | 11-deoxy Prostaglandin E1 | 500 μg | 364 |
| Cayman2015 | 13519 | Celastramycin A | 1 mg | 1372 |
| Cayman2015 | 13519 | Celastramycin A | 10 mg | 11256 |
| Cayman2015 | 13519 | Celastramycin A | 5 mg | 6384 |
| Cayman2015 | 13521 | Oxalomalic Acid (sodium salt) | 1 mg | 350 |
| Cayman2015 | 13521 | Oxalomalic Acid (sodium salt) | 10 mg | 1750 |
| Cayman2015 | 13521 | Oxalomalic Acid (sodium salt) | 25 mg | 3934 |
| Cayman2015 | 13521 | Oxalomalic Acid (sodium salt) | 5 mg | 1050 |
| Cayman2015 | 13523 | Apelin-13 | 1 mg | 588 |
| Cayman2015 | 13523 | Apelin-13 | 10 mg | 4704 |
| Cayman2015 | 13523 | Apelin-13 | 25 mg | 10290 |
| Cayman2015 | 13523 | Apelin-13 | 5 mg | 2646 |
| Cayman2015 | 13524 | Apelin-36 | 1 mg | 4340 |
| Cayman2015 | 13524 | Apelin-36 | 5 mg | 18256 |
| Cayman2015 | 13524 | Apelin-36 | 500 μg | 2282 |
| Cayman2015 | 13526 | (+)-Warfarin | 1 mg | 910 |
| Cayman2015 | 13526 | (+)-Warfarin | 10 mg | 7280 |
| Cayman2015 | 13526 | (+)-Warfarin | 25 mg | 11382 |
| Cayman2015 | 13526 | (+)-Warfarin | 5 mg | 3864 |
| Cayman2015 | 13527 | Pseudolaric Acid B | 1 mg | 938 |
| Cayman2015 | 13527 | Pseudolaric Acid B | 10 mg | 5488 |
| Cayman2015 | 13527 | Pseudolaric Acid B | 5 mg | 3920 |
| Cayman2015 | 13527 | Pseudolaric Acid B | 500 μg | 490 |
| Cayman2015 | 13530 | Bicyclo Prostaglandin E1 | 1 mg | 980 |
| Cayman2015 | 13530 | Bicyclo Prostaglandin E1 | 10 mg | 7840 |
| Cayman2015 | 13530 | Bicyclo Prostaglandin E1 | 5 mg | 4410 |
| Cayman2015 | 13531 | (-)-Warfarin | 1 mg | 910 |
| Cayman2015 | 13531 | (-)-Warfarin | 10 mg | 7280 |
| Cayman2015 | 13531 | (-)-Warfarin | 25 mg | 11382 |
| Cayman2015 | 13531 | (-)-Warfarin | 5 mg | 3864 |
| Cayman2015 | 13532 | 17-phenyl trinor Prostaglandin E2 ethyl amide | 1 mg | 1064 |
| Cayman2015 | 13532 | 17-phenyl trinor Prostaglandin E2 ethyl amide | 10 mg | 8512 |
| Cayman2015 | 13532 | 17-phenyl trinor Prostaglandin E2 ethyl amide | 5 mg | 4788 |
| Cayman2015 | 13533 | E-64d | 1 mg | 686 |
| Cayman2015 | 13533 | E-64d | 10 mg | 5488 |
| Cayman2015 | 13533 | E-64d | 25 mg | 12012 |
| Cayman2015 | 13533 | E-64d | 5 mg | 3094 |
| Cayman2015 | 13535 | Histone H2A Polyclonal Antibody | 1 ea | 3500 |
| Cayman2015 | 13537 | eIF3G Polyclonal Antibody (aa 200-250) | 1 ea | 3710 |
| Cayman2015 | 13538 | Histone H2B (C-Term) Polyclonal Antibody | 1 ea | 3962 |
| Cayman2015 | 13540 | Histone H3 (Phospho-Ser28) Monoclonal Antibody (Clone 117C826) | 1 ea | 4424 |
| Cayman2015 | 13543 | Histone H4 Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13554 | LSD1 Polyclonal Antibody (aa 100-150) | 1 ea | 3710 |
| Cayman2015 | 13557 | PARP (Cleaved) Monoclonal Antibody | 1 ea | 4130 |
| Cayman2015 | 13560 | Soluble Epoxide Hydrolase (FL) Polyclonal Antibody | 1 ea | 2926 |
| Cayman2015 | 13562 | Fatostatin (hydrobromide) | 10 mg | 1274 |
| Cayman2015 | 13562 | Fatostatin (hydrobromide) | 25 mg | 2954 |
| Cayman2015 | 13562 | Fatostatin (hydrobromide) | 5 mg | 910 |
| Cayman2015 | 13562 | Fatostatin (hydrobromide) | 50 mg | 5012 |
| Cayman2015 | 13563 | FIPI | 1 mg | 490 |
| Cayman2015 | 13563 | FIPI | 10 mg | 2702 |
| Cayman2015 | 13563 | FIPI | 25 mg | 6132 |
| Cayman2015 | 13563 | FIPI | 5 mg | 1470 |
| Cayman2015 | 13564 | tetranor-PGDM lactone | 100 μg | 6048 |
| Cayman2015 | 13564 | tetranor-PGDM lactone | 25 μg | 1680 |
| Cayman2015 | 13564 | tetranor-PGDM lactone | 50 μg | 3192 |
| Cayman2015 | 13566 | (±)-Warfarin | 1 g | 252 |
| Cayman2015 | 13570 | N-Benzylacetamidine (hydrobromide) | 10 mg | 1386 |
| Cayman2015 | 13570 | N-Benzylacetamidine (hydrobromide) | 100 mg | 10192 |
| Cayman2015 | 13570 | N-Benzylacetamidine (hydrobromide) | 5 mg | 728 |
| Cayman2015 | 13570 | N-Benzylacetamidine (hydrobromide) | 50 mg | 5824 |
| Cayman2015 | 13571 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | 10 μg | 1120 |
| Cayman2015 | 13571 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | 25 μg | 2660 |
| Cayman2015 | 13571 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1α | 50 μg | 5040 |
| Cayman2015 | 13574 | 3-bromo-5-phenyl Salicylic Acid | 1 mg | 714 |
| Cayman2015 | 13574 | 3-bromo-5-phenyl Salicylic Acid | 10 mg | 5712 |
| Cayman2015 | 13574 | 3-bromo-5-phenyl Salicylic Acid | 25 mg | 12502 |
| Cayman2015 | 13574 | 3-bromo-5-phenyl Salicylic Acid | 5 mg | 3220 |
| Cayman2015 | 13576 | YM-201636 | 1 mg | 560 |
| Cayman2015 | 13576 | YM-201636 | 10 mg | 3360 |
| Cayman2015 | 13576 | YM-201636 | 5 mg | 2240 |
| Cayman2015 | 13579 | Salinomycin (sodium salt) | 10 mg | 322 |
| Cayman2015 | 13579 | Salinomycin (sodium salt) | 100 mg | 1820 |
| Cayman2015 | 13579 | Salinomycin (sodium salt) | 5 mg | 182 |
| Cayman2015 | 13579 | Salinomycin (sodium salt) | 50 mg | 1092 |
| Cayman2015 | 13580 | HDMAPP (ammonium salt) | 1 mg | 1624 |
| Cayman2015 | 13580 | HDMAPP (ammonium salt) | 10 mg | 11956 |
| Cayman2015 | 13580 | HDMAPP (ammonium salt) | 5 mg | 6832 |
| Cayman2015 | 13580 | HDMAPP (ammonium salt) | 500 μg | 854 |
| Cayman2015 | 13581 | Phosphine-biotin | 1 mg | 2982 |
| Cayman2015 | 13581 | Phosphine-biotin | 5 mg | 12544 |
| Cayman2015 | 13581 | Phosphine-biotin | 500 μg | 1568 |
| Cayman2015 | 13582 | Toll-Like Receptor 1 Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13583 | 1-Aminodecylidene bis-Phosphonic Acid (sodium salt) | 1 mg | 826 |
| Cayman2015 | 13583 | 1-Aminodecylidene bis-Phosphonic Acid (sodium salt) | 10 mg | 6608 |
| Cayman2015 | 13583 | 1-Aminodecylidene bis-Phosphonic Acid (sodium salt) | 5 mg | 3724 |
| Cayman2015 | 13586 | Toll-Like Receptor 12 Polyclonal Antibody | 1 ea | 4802 |
| Cayman2015 | 13587 | Toll-Like Receptor 2 Monoclonal Antibody (Clone TL2.1) | 1 ea | 4088 |
| Cayman2015 | 13588 | Toll-Like Receptor 3 Monoclonal Antibody (Clone 40C1285.6) | 1 ea | 3710 |
| Cayman2015 | 13589 | Toll-Like Receptor 4 Monoclonal Antibody (Clone HTA125) | 1 ea | 4186 |
| Cayman2015 | 13591 | Toll-Like Receptor 7 Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13592 | Toll-Like Receptor 8 Monoclonal Antibody (Clone 44C143) | 1 ea | 3710 |
| Cayman2015 | 13593 | Toll-Like Receptor 9 Monoclonal Antibody (Clone 26C593.2) | 1 ea | 3892 |
| Cayman2015 | 13596 | XAV939 | 1 mg | 140 |
| Cayman2015 | 13596 | XAV939 | 10 mg | 1120 |
| Cayman2015 | 13596 | XAV939 | 25 mg | 2450 |
| Cayman2015 | 13596 | XAV939 | 5 mg | 630 |
| Cayman2015 | 13597 | Ku-0063794 | 10 mg | 1890 |
| Cayman2015 | 13597 | Ku-0063794 | 100 mg | 7350 |
| Cayman2015 | 13597 | Ku-0063794 | 5 mg | 1050 |
| Cayman2015 | 13597 | Ku-0063794 | 50 mg | 5250 |
| Cayman2015 | 13598 | IWR-1-exo | 10 mg | 1442 |
| Cayman2015 | 13598 | IWR-1-exo | 25 mg | 3402 |
| Cayman2015 | 13598 | IWR-1-exo | 5 mg | 756 |
| Cayman2015 | 13598 | IWR-1-exo | 50 mg | 6048 |
| Cayman2015 | 13600 | MK 0457 | 100 mg | 3472 |
| Cayman2015 | 13600 | MK 0457 | 25 mg | 966 |
| Cayman2015 | 13600 | MK 0457 | 250 mg | 6286 |
| Cayman2015 | 13600 | MK 0457 | 50 mg | 1834 |
| Cayman2015 | 13601 | ZM 447439 | 10 mg | 1204 |
| Cayman2015 | 13601 | ZM 447439 | 5 mg | 672 |
| Cayman2015 | 13601 | ZM 447439 | 50 mg | 4032 |
| Cayman2015 | 13603 | S-Adenosylhomocysteine | 10 mg | 672 |
| Cayman2015 | 13603 | S-Adenosylhomocysteine | 25 mg | 1316 |
| Cayman2015 | 13603 | S-Adenosylhomocysteine | 5 mg | 350 |
| Cayman2015 | 13603 | S-Adenosylhomocysteine | 50 mg | 2282 |
| Cayman2015 | 13604 | WYE-354 | 10 mg | 2002 |
| Cayman2015 | 13604 | WYE-354 | 25 mg | 4732 |
| Cayman2015 | 13604 | WYE-354 | 5 mg | 1050 |
| Cayman2015 | 13604 | WYE-354 | 50 mg | 8400 |
| Cayman2015 | 13608 | (+)-CP 55,940 | 1 mg | 490 |
| Cayman2015 | 13608 | (+)-CP 55,940 | 10 mg | 3136 |
| Cayman2015 | 13608 | (+)-CP 55,940 | 25 mg | 6860 |
| Cayman2015 | 13608 | (+)-CP 55,940 | 5 mg | 1764 |
| Cayman2015 | 13609 | 13,14-dihydro-16,16-difluoro Prostaglandin F2α | 1 mg | 3584 |
| Cayman2015 | 13609 | 13,14-dihydro-16,16-difluoro Prostaglandin F2α | 100 μg | 448 |
| Cayman2015 | 13609 | 13,14-dihydro-16,16-difluoro Prostaglandin F2α | 500 μg | 2016 |
| Cayman2015 | 13610 | 13,14-dihydro Prostaglandin E1 | 1 mg | 980 |
| Cayman2015 | 13610 | 13,14-dihydro Prostaglandin E1 | 10 mg | 7252 |
| Cayman2015 | 13610 | 13,14-dihydro Prostaglandin E1 | 5 mg | 4144 |
| Cayman2015 | 13610 | 13,14-dihydro Prostaglandin E1 | 500 μg | 518 |
| Cayman2015 | 13612 | 13,14-dihydro-16,16-difluoro Prostaglandin D2 | 1 mg | 3472 |
| Cayman2015 | 13612 | 13,14-dihydro-16,16-difluoro Prostaglandin D2 | 100 μg | 434 |
| Cayman2015 | 13612 | 13,14-dihydro-16,16-difluoro Prostaglandin D2 | 500 μg | 1960 |
| Cayman2015 | 13613 | GDC 0449 | 10 mg | 1890 |
| Cayman2015 | 13613 | GDC 0449 | 25 mg | 3416 |
| Cayman2015 | 13613 | GDC 0449 | 5 mg | 1050 |
| Cayman2015 | 13613 | GDC 0449 | 50 mg | 4732 |
| Cayman2015 | 13615 | CAY10614 | 1 mg | 602 |
| Cayman2015 | 13615 | CAY10614 | 10 mg | 4816 |
| Cayman2015 | 13615 | CAY10614 | 25 mg | 10542 |
| Cayman2015 | 13615 | CAY10614 | 5 mg | 2716 |
| Cayman2015 | 13616 | (R)-Lisofylline | 1 mg | 798 |
| Cayman2015 | 13616 | (R)-Lisofylline | 10 mg | 6384 |
| Cayman2015 | 13616 | (R)-Lisofylline | 5 mg | 3598 |
| Cayman2015 | 13617 | (S)-Lisofylline | 1 mg | 798 |
| Cayman2015 | 13617 | (S)-Lisofylline | 10 mg | 6384 |
| Cayman2015 | 13617 | (S)-Lisofylline | 5 mg | 3598 |
| Cayman2015 | 13618 | Rivenprost | 1 mg | 2002 |
| Cayman2015 | 13618 | Rivenprost | 5 mg | 8302 |
| Cayman2015 | 13618 | Rivenprost | 500 μg | 1050 |
| Cayman2015 | 13619 | ACS 67 | 1 mg | 882 |
| Cayman2015 | 13619 | ACS 67 | 10 mg | 7056 |
| Cayman2015 | 13619 | ACS 67 | 25 mg | 15442 |
| Cayman2015 | 13619 | ACS 67 | 5 mg | 3976 |
| Cayman2015 | 13620 | AL 6598 | 1 mg | 2660 |
| Cayman2015 | 13620 | AL 6598 | 10 mg | 19320 |
| Cayman2015 | 13620 | AL 6598 | 5 mg | 11060 |
| Cayman2015 | 13620 | AL 6598 | 500 μg | 1372 |
| Cayman2015 | 13621 | Pristimerin | 10 mg | 2100 |
| Cayman2015 | 13621 | Pristimerin | 25 mg | 4732 |
| Cayman2015 | 13621 | Pristimerin | 5 mg | 1106 |
| Cayman2015 | 13621 | Pristimerin | 50 mg | 8512 |
| Cayman2015 | 13622 | AS-041164 | 10 mg | 1036 |
| Cayman2015 | 13622 | AS-041164 | 25 mg | 2352 |
| Cayman2015 | 13622 | AS-041164 | 5 mg | 812 |
| Cayman2015 | 13622 | AS-041164 | 50 mg | 3976 |
| Cayman2015 | 13623 | Topiramate | 1 g | 9800 |
| Cayman2015 | 13623 | Topiramate | 100 mg | 1330 |
| Cayman2015 | 13623 | Topiramate | 50 mg | 700 |
| Cayman2015 | 13623 | Topiramate | 500 mg | 5600 |
| Cayman2015 | 13624 | Icariin | 1 g | 854 |
| Cayman2015 | 13624 | Icariin | 10 g | 6832 |
| Cayman2015 | 13624 | Icariin | 25 g | 14952 |
| Cayman2015 | 13624 | Icariin | 5 g | 3850 |
| Cayman2015 | 13626 | AFP 07 (free acid) | 1 mg | 2604 |
| Cayman2015 | 13626 | AFP 07 (free acid) | 5 mg | 10976 |
| Cayman2015 | 13626 | AFP 07 (free acid) | 500 μg | 1372 |
| Cayman2015 | 13627 | Lansoprazole | 1 g | 882 |
| Cayman2015 | 13627 | Lansoprazole | 10 g | 6468 |
| Cayman2015 | 13627 | Lansoprazole | 5 g | 3696 |
| Cayman2015 | 13627 | Lansoprazole | 500 mg | 462 |
| Cayman2015 | 13628 | Salidroside | 1 mg | 2576 |
| Cayman2015 | 13628 | Salidroside | 10 mg | 19012 |
| Cayman2015 | 13628 | Salidroside | 5 mg | 10864 |
| Cayman2015 | 13628 | Salidroside | 500 μg | 1358 |
| Cayman2015 | 13629 | Risperidone | 10 mg | 770 |
| Cayman2015 | 13629 | Risperidone | 100 mg | 6160 |
| Cayman2015 | 13629 | Risperidone | 50 mg | 3472 |
| Cayman2015 | 13630 | 13,14-dihydro-15(R)-Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13630 | 13,14-dihydro-15(R)-Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13630 | 13,14-dihydro-15(R)-Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13631 | UNC0224 | 1 mg | 532 |
| Cayman2015 | 13631 | UNC0224 | 10 mg | 2352 |
| Cayman2015 | 13631 | UNC0224 | 5 mg | 1512 |
| Cayman2015 | 13631 | UNC0224 | 50 mg | 10920 |
| Cayman2015 | 13632 | Tiaprost | 1 mg | 742 |
| Cayman2015 | 13632 | Tiaprost | 5 mg | 3136 |
| Cayman2015 | 13632 | Tiaprost | 500 μg | 392 |
| Cayman2015 | 13633 | JWH 019 | 10 mg | 1302 |
| Cayman2015 | 13633 | JWH 019 | 25 mg | 3094 |
| Cayman2015 | 13633 | JWH 019 | 5 mg | 686 |
| Cayman2015 | 13634 | JWH 250 | 10 mg | 1484 |
| Cayman2015 | 13634 | JWH 250 | 25 mg | 3528 |
| Cayman2015 | 13634 | JWH 250 | 5 mg | 784 |
| Cayman2015 | 13635 | 13,14-dihydro-16,16-difluoro Prostaglandin J2 | 1 mg | 3248 |
| Cayman2015 | 13635 | 13,14-dihydro-16,16-difluoro Prostaglandin J2 | 100 μg | 406 |
| Cayman2015 | 13635 | 13,14-dihydro-16,16-difluoro Prostaglandin J2 | 500 μg | 1834 |
| Cayman2015 | 13636 | JWH 398 | 1 mg | 490 |
| Cayman2015 | 13636 | JWH 398 | 10 mg | 1960 |
| Cayman2015 | 13636 | JWH 398 | 25 mg | 4060 |
| Cayman2015 | 13636 | JWH 398 | 5 mg | 1330 |
| Cayman2015 | 13639 | WZ811 | 1 mg | 196 |
| Cayman2015 | 13639 | WZ811 | 10 mg | 1568 |
| Cayman2015 | 13639 | WZ811 | 25 mg | 3430 |
| Cayman2015 | 13639 | WZ811 | 5 mg | 882 |
| Cayman2015 | 13640 | Mouse Anti-6HIS IgG:SureLight? APC | 1 ea | 4710 |
| Cayman2015 | 13641 | NVP-AEW541 (hydrochloride) | 1 mg | 1330 |
| Cayman2015 | 13641 | NVP-AEW541 (hydrochloride) | 10 mg | 8820 |
| Cayman2015 | 13641 | NVP-AEW541 (hydrochloride) | 5 mg | 5040 |
| Cayman2015 | 13641 | NVP-AEW541 (hydrochloride) | 500 μg | 910 |
| Cayman2015 | 13642 | Alendronate (sodium hydrate) | 1 g | 2128 |
| Cayman2015 | 13642 | Alendronate (sodium hydrate) | 100 mg | 266 |
| Cayman2015 | 13642 | Alendronate (sodium hydrate) | 250 mg | 630 |
| Cayman2015 | 13642 | Alendronate (sodium hydrate) | 500 mg | 1204 |
| Cayman2015 | 13643 | PP242 | 1 mg | 238 |
| Cayman2015 | 13643 | PP242 | 10 mg | 1652 |
| Cayman2015 | 13643 | PP242 | 5 mg | 952 |
| Cayman2015 | 13644 | Aspalatone | 10 mg | 742 |
| Cayman2015 | 13644 | Aspalatone | 100 mg | 5488 |
| Cayman2015 | 13644 | Aspalatone | 5 mg | 392 |
| Cayman2015 | 13644 | Aspalatone | 50 mg | 3136 |
| Cayman2015 | 13645 | PX 866 | 1 mg | 826 |
| Cayman2015 | 13645 | PX 866 | 10 mg | 5782 |
| Cayman2015 | 13645 | PX 866 | 5 mg | 3514 |
| Cayman2015 | 13648 | Alfuzosin (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 13648 | Alfuzosin (hydrochloride) | 25 mg | 2212 |
| Cayman2015 | 13648 | Alfuzosin (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 13648 | Alfuzosin (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13653 | ABT-869 | 1 mg | 686 |
| Cayman2015 | 13653 | ABT-869 | 10 mg | 2226 |
| Cayman2015 | 13653 | ABT-869 | 5 mg | 1344 |
| Cayman2015 | 13655 | Adapalene | 1 g | 15456 |
| Cayman2015 | 13655 | Adapalene | 100 mg | 1932 |
| Cayman2015 | 13655 | Adapalene | 250 mg | 4592 |
| Cayman2015 | 13655 | Adapalene | 500 mg | 8694 |
| Cayman2015 | 13657 | (±)-Clopidogrel (hydrochloride) | 10 mg | 1568 |
| Cayman2015 | 13657 | (±)-Clopidogrel (hydrochloride) | 50 mg | 7000 |
| Cayman2015 | 13659 | IWR-1-endo | 10 mg | 1442 |
| Cayman2015 | 13659 | IWR-1-endo | 25 mg | 3402 |
| Cayman2015 | 13659 | IWR-1-endo | 5 mg | 756 |
| Cayman2015 | 13659 | IWR-1-endo | 50 mg | 6048 |
| Cayman2015 | 13660 | 13,14-dihydro-19(R)-hydroxy Prostaglandin E1 | 100 μg | 1932 |
| Cayman2015 | 13660 | 13,14-dihydro-19(R)-hydroxy Prostaglandin E1 | 50 μg | 1204 |
| Cayman2015 | 13660 | 13,14-dihydro-19(R)-hydroxy Prostaglandin E1 | 500 μg | 7700 |
| Cayman2015 | 13661 | YK-4-279 | 1 mg | 490 |
| Cayman2015 | 13661 | YK-4-279 | 10 mg | 2240 |
| Cayman2015 | 13661 | YK-4-279 | 5 mg | 1330 |
| Cayman2015 | 13661 | YK-4-279 | 50 mg | 9800 |
| Cayman2015 | 13662 | Arecoline (hydrobromide) | 100 mg | 196 |
| Cayman2015 | 13662 | Arecoline (hydrobromide) | 250 mg | 462 |
| Cayman2015 | 13662 | Arecoline (hydrobromide) | 500 mg | 882 |
| Cayman2015 | 13664 | S32826 | 1 mg | 406 |
| Cayman2015 | 13664 | S32826 | 10 mg | 3248 |
| Cayman2015 | 13664 | S32826 | 25 mg | 7112 |
| Cayman2015 | 13664 | S32826 | 5 mg | 1834 |
| Cayman2015 | 13665 | YS121 | 1 mg | 602 |
| Cayman2015 | 13665 | YS121 | 10 mg | 4816 |
| Cayman2015 | 13665 | YS121 | 25 mg | 10542 |
| Cayman2015 | 13665 | YS121 | 5 mg | 2716 |
| Cayman2015 | 13667 | Muscimol | 10 mg | 1624 |
| Cayman2015 | 13667 | Muscimol | 25 mg | 3850 |
| Cayman2015 | 13667 | Muscimol | 5 mg | 854 |
| Cayman2015 | 13668 | JZL 195 | 10 mg | 1274 |
| Cayman2015 | 13668 | JZL 195 | 100 mg | 9408 |
| Cayman2015 | 13668 | JZL 195 | 5 mg | 672 |
| Cayman2015 | 13668 | JZL 195 | 50 mg | 5376 |
| Cayman2015 | 13670 | CAY10618 | 1 mg | 406 |
| Cayman2015 | 13670 | CAY10618 | 10 mg | 2940 |
| Cayman2015 | 13670 | CAY10618 | 5 mg | 1680 |
| Cayman2015 | 13670 | CAY10618 | 500 μg | 210 |
| Cayman2015 | 13671 | Wortmannin-Rapamycin Conjugate | 1 mg | 3304 |
| Cayman2015 | 13671 | Wortmannin-Rapamycin Conjugate | 5 mg | 13888 |
| Cayman2015 | 13671 | Wortmannin-Rapamycin Conjugate | 500 μg | 1736 |
| Cayman2015 | 13673 | ZK118182 isopropyl ester | 100 μg | 2366 |
| Cayman2015 | 13673 | ZK118182 isopropyl ester | 500 μg | 10654 |
| Cayman2015 | 13679 | 13,14-epoxy Fluprostenol isopropyl ester | 1 mg | 1190 |
| Cayman2015 | 13679 | 13,14-epoxy Fluprostenol isopropyl ester | 10 mg | 9520 |
| Cayman2015 | 13679 | 13,14-epoxy Fluprostenol isopropyl ester | 5 mg | 5362 |
| Cayman2015 | 13680 | 15-keto Prostaglandin E1 | 1 mg | 1386 |
| Cayman2015 | 13680 | 15-keto Prostaglandin E1 | 10 mg | 10192 |
| Cayman2015 | 13680 | 15-keto Prostaglandin E1 | 5 mg | 5824 |
| Cayman2015 | 13680 | 15-keto Prostaglandin E1 | 500 μg | 728 |
| Cayman2015 | 13686 | Chidamide | 1 mg | 602 |
| Cayman2015 | 13686 | Chidamide | 10 mg | 4816 |
| Cayman2015 | 13686 | Chidamide | 25 mg | 10542 |
| Cayman2015 | 13686 | Chidamide | 5 mg | 2716 |
| Cayman2015 | 13687 | CAY10622 | 1 mg | 686 |
| Cayman2015 | 13687 | CAY10622 | 10 mg | 5488 |
| Cayman2015 | 13687 | CAY10622 | 5 mg | 3094 |
| Cayman2015 | 13689 | GW 1929 | 1 mg | 435 |
| Cayman2015 | 13689 | GW 1929 | 25 mg | 5445 |
| Cayman2015 | 13689 | GW 1929 | 5 mg | 1305 |
| Cayman2015 | 13691 | Tubacin | 1 mg | 1190 |
| Cayman2015 | 13691 | Tubacin | 5 mg | 3864 |
| Cayman2015 | 13692 | Nitazoxanide | 10 mg | 546 |
| Cayman2015 | 13692 | Nitazoxanide | 100 mg | 4368 |
| Cayman2015 | 13692 | Nitazoxanide | 250 mg | 9562 |
| Cayman2015 | 13692 | Nitazoxanide | 50 mg | 2464 |
| Cayman2015 | 13693 | Tizoxanide | 1 mg | 350 |
| Cayman2015 | 13693 | Tizoxanide | 10 mg | 2450 |
| Cayman2015 | 13693 | Tizoxanide | 25 mg | 5460 |
| Cayman2015 | 13693 | Tizoxanide | 5 mg | 1372 |
| Cayman2015 | 13695 | CAY10638 | 1 mg | 350 |
| Cayman2015 | 13695 | CAY10638 | 10 mg | 2282 |
| Cayman2015 | 13695 | CAY10638 | 25 mg | 5250 |
| Cayman2015 | 13695 | CAY10638 | 5 mg | 1232 |
| Cayman2015 | 13697 | (R)-MG132 | 1 mg | 602 |
| Cayman2015 | 13697 | (R)-MG132 | 10 mg | 4816 |
| Cayman2015 | 13697 | (R)-MG132 | 25 mg | 10542 |
| Cayman2015 | 13697 | (R)-MG132 | 5 mg | 2716 |
| Cayman2015 | 13700 | Cavβ1 Calcium Channel Monoclonal Antibody (Clone S7-18) | 100 μg | 5880 |
| Cayman2015 | 13701 | Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10-7) | 100 μg | 5880 |
| Cayman2015 | 13702 | Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57-46) | 100 μg | 5880 |
| Cayman2015 | 13703 | Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38-8) | 100 μg | 5880 |
| Cayman2015 | 13704 | Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10) | 100 μg | 5880 |
| Cayman2015 | 13705 | HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) | 100 μg | 5880 |
| Cayman2015 | 13706 | Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A-9) | 100 μg | 5880 |
| Cayman2015 | 13707 | HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) | 100 μg | 5880 |
| Cayman2015 | 13708 | HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) | 100 μg | 5880 |
| Cayman2015 | 13709 | HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) | 100 μg | 5880 |
| Cayman2015 | 13710 | 15(R)-Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13710 | 15(R)-Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13710 | 15(R)-Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13711 | KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) | 100 μg | 5880 |
| Cayman2015 | 13712 | KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) | 100 μg | 5880 |
| Cayman2015 | 13713 | KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43-6) | 100 μg | 5880 |
| Cayman2015 | 13714 | Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21-32) | 100 μg | 5880 |
| Cayman2015 | 13715 | Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24-1) | 100 μg | 5880 |
| Cayman2015 | 13716 | Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25-35) | 100 μg | 5880 |
| Cayman2015 | 13717 | Kv3.1b Potassium Channel Monoclonal Antibody (Clone S16B-8) | 100 μg | 5880 |
| Cayman2015 | 13718 | Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68-6) | 100 μg | 5880 |
| Cayman2015 | 13719 | TRPC4 Calcium Channel Monoclonal Antibody (Clone S77-15) | 100 μg | 5880 |
| Cayman2015 | 13720 | TRPM7 Ion Channel Ser/Thr Kinase Monoclonal Antibody (Clone S74-25) | 100 μg | 5880 |
| Cayman2015 | 13721 | TRPV3 Channel Monoclonal Antibody (Clone S15-4) | 100 μg | 5880 |
| Cayman2015 | 13722 | Ubiquitin Monoclonal Antibody (Clone 5B9-B3) | 200 μg | 6000 |
| Cayman2015 | 13722 | Ubiquitin Monoclonal Antibody (Clone 5B9-B3) | 50 μg | 2940 |
| Cayman2015 | 13723 | Ubiquitin Monoclonal Antibody (Clone 6C11-B3) | 200 μg | 6000 |
| Cayman2015 | 13723 | Ubiquitin Monoclonal Antibody (Clone 6C11-B3) | 50 μg | 2940 |
| Cayman2015 | 13724 | Ubiquitin Polyclonal Antibody | 200 μg | 6000 |
| Cayman2015 | 13724 | Ubiquitin Polyclonal Antibody | 50 μg | 2920 |
| Cayman2015 | 13725 | Acetyl Lysine Polyclonal Antibody-biotin | 400 μL | 6900 |
| Cayman2015 | 13726 | Acetyl Lysine Polyclonal Antibody HRP Conjugate | 400 μL | 7220 |
| Cayman2015 | 13727 | Methylated Lysine Polyclonal Antibody | 400 μL | 6080 |
| Cayman2015 | 13728 | Methylated Lysine Polyclonal Antibody-biotin | 400 μL | 6900 |
| Cayman2015 | 13729 | Methylated Lysine Polyclonal Antibody HRP Conjugate | 400 μL | 7220 |
| Cayman2015 | 13730 | 15(S)-15-methyl Prostaglandin E1 | 1 mg | 1176 |
| Cayman2015 | 13730 | 15(S)-15-methyl Prostaglandin E1 | 10 mg | 9408 |
| Cayman2015 | 13730 | 15(S)-15-methyl Prostaglandin E1 | 5 mg | 5292 |
| Cayman2015 | 13731 | SET7/9 Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13733 | Akt1 (Phospho-Ser473) Monoclonal Antibody (Clone 104A282) | 1 ea | 4130 |
| Cayman2015 | 13740 | Butaprost | 1 mg | 1624 |
| Cayman2015 | 13740 | Butaprost | 10 mg | 11956 |
| Cayman2015 | 13740 | Butaprost | 5 mg | 6832 |
| Cayman2015 | 13740 | Butaprost | 500 μg | 854 |
| Cayman2015 | 13741 | Butaprost (free acid) | 1 mg | 2100 |
| Cayman2015 | 13741 | Butaprost (free acid) | 10 mg | 15484 |
| Cayman2015 | 13741 | Butaprost (free acid) | 5 mg | 8848 |
| Cayman2015 | 13741 | Butaprost (free acid) | 500 μg | 1106 |
| Cayman2015 | 13745 | (R)-Butaprost | 1 mg | 1540 |
| Cayman2015 | 13745 | (R)-Butaprost | 10 mg | 12320 |
| Cayman2015 | 13745 | (R)-Butaprost | 5 mg | 6930 |
| Cayman2015 | 13747 | CAY10408 | 1 mg | 1708 |
| Cayman2015 | 13747 | CAY10408 | 10 mg | 13664 |
| Cayman2015 | 13747 | CAY10408 | 5 mg | 7686 |
| Cayman2015 | 13749 | Western Blot Kit Goat Anti-Mouse:SureLight? P3 | 1 ea | 3075 |
| Cayman2015 | 13750 | 16,16-dimethyl Prostaglandin E1 | 1 mg | 826 |
| Cayman2015 | 13750 | 16,16-dimethyl Prostaglandin E1 | 10 mg | 6608 |
| Cayman2015 | 13750 | 16,16-dimethyl Prostaglandin E1 | 5 mg | 3724 |
| Cayman2015 | 13751 | NF-κB (p65) NLS Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 13752 | NF-κB (p65) Monoclonal Antibody (Clone 112A1021) | 1 ea | 3990 |
| Cayman2015 | 13753 | NF-κB (p65) Polyclonal Antibody (aa 538-546) | 1 ea | 3612 |
| Cayman2015 | 13755 | NF-κB (p50) Monoclonal Antibody (Clone 2J10D7) | 1 ea | 4046 |
| Cayman2015 | 13756 | NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021) | 1 ea | 3836 |
| Cayman2015 | 13757 | NF-κB (p65) Polyclonal Antibody (aa 2-17) | 1 ea | 3374 |
| Cayman2015 | 13767 | Western Blot Kit Goat Anti-Rabbit:SureLight? P3 | 1 ea | 3075 |
| Cayman2015 | 13768 | Western Blot Kit Goat Anti-Mouse:SureLight? PE | 1 ea | 3075 |
| Cayman2015 | 13769 | Western Blot Kit Goat Anti-Rabbit:SureLight? PE | 1 ea | 3075 |
| Cayman2015 | 13770 | 16-phenyl tetranor Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13770 | 16-phenyl tetranor Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13770 | 16-phenyl tetranor Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13775 | MeCP2 Polyclonal Antibody | 1 ea | 3374 |
| Cayman2015 | 13780 | SET7/9 (FL) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 13782 | I2PP2A/SET Polyclonal Antibody | 1 ea | 3710 |
| Cayman2015 | 13784 | Histone H3.3 Polyclonal Antibody | 1 ea | 3780 |
| Cayman2015 | 13787 | JMJD6 Peptide Affinity-Purified Polyclonal Antibody | 1 ea | 3528 |
| Cayman2015 | 13789 | TIP60 Polyclonal Antibody | 1 ea | 3878 |
| Cayman2015 | 13790 | TRF2 Monoclonal Antibody (Clone 4A794.15) | 1 ea | 4242 |
| Cayman2015 | 13791 | TRF2 Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 13800 | 16,16-dimethyl-6-keto Prostaglandin E1 | 1 mg | 714 |
| Cayman2015 | 13800 | 16,16-dimethyl-6-keto Prostaglandin E1 | 10 mg | 5712 |
| Cayman2015 | 13800 | 16,16-dimethyl-6-keto Prostaglandin E1 | 5 mg | 3220 |
| Cayman2015 | 13801 | (±)-epi CP 47,497 (exempt preparation) | 10 mg | 1470 |
| Cayman2015 | 13801 | (±)-epi CP 47,497 (exempt preparation) | 25 mg | 3472 |
| Cayman2015 | 13801 | (±)-epi CP 47,497 (exempt preparation) | 5 mg | 770 |
| Cayman2015 | 13802 | (±)3-epi CP 47,497-C8-homolog (exempt preparation) | 10 mg | 1470 |
| Cayman2015 | 13802 | (±)3-epi CP 47,497-C8-homolog (exempt preparation) | 25 mg | 3472 |
| Cayman2015 | 13802 | (±)3-epi CP 47,497-C8-homolog (exempt preparation) | 5 mg | 770 |
| Cayman2015 | 13803 | (±)5-epi CP 55,940 | 10 mg | 2310 |
| Cayman2015 | 13803 | (±)5-epi CP 55,940 | 25 mg | 5488 |
| Cayman2015 | 13803 | (±)5-epi CP 55,940 | 5 mg | 1218 |
| Cayman2015 | 13804 | OU749 | 1 mg | 252 |
| Cayman2015 | 13804 | OU749 | 10 mg | 2016 |
| Cayman2015 | 13804 | OU749 | 25 mg | 4410 |
| Cayman2015 | 13804 | OU749 | 5 mg | 1134 |
| Cayman2015 | 13810 | Limaprost | 1 mg | 798 |
| Cayman2015 | 13810 | Limaprost | 10 mg | 6384 |
| Cayman2015 | 13810 | Limaprost | 5 mg | 3598 |
| Cayman2015 | 13810 | Limaprost | 50 mg | 27930 |
| Cayman2015 | 13812 | 17β-hydroxy Wortmannin | 1 mg | 1218 |
| Cayman2015 | 13812 | 17β-hydroxy Wortmannin | 10 mg | 9016 |
| Cayman2015 | 13812 | 17β-hydroxy Wortmannin | 5 mg | 5152 |
| Cayman2015 | 13812 | 17β-hydroxy Wortmannin | 500 μg | 644 |
| Cayman2015 | 13813 | Axitinib | 100 mg | 1652 |
| Cayman2015 | 13813 | Axitinib | 50 mg | 868 |
| Cayman2015 | 13813 | Axitinib | 500 mg | 6944 |
| Cayman2015 | 13816 | IDE1 | 1 mg | 686 |
| Cayman2015 | 13816 | IDE1 | 10 mg | 2408 |
| Cayman2015 | 13816 | IDE1 | 5 mg | 1372 |
| Cayman2015 | 13817 | IDE2 | 1 mg | 350 |
| Cayman2015 | 13817 | IDE2 | 10 mg | 2100 |
| Cayman2015 | 13817 | IDE2 | 5 mg | 1316 |
| Cayman2015 | 13820 | Misoprostol | 1 mg | 210 |
| Cayman2015 | 13820 | Misoprostol | 10 mg | 1162 |
| Cayman2015 | 13820 | Misoprostol | 25 mg | 2632 |
| Cayman2015 | 13820 | Misoprostol | 5 mg | 840 |
| Cayman2015 | 13821 | Misoprostol (free acid) | 1 mg | 546 |
| Cayman2015 | 13821 | Misoprostol (free acid) | 10 mg | 4368 |
| Cayman2015 | 13821 | Misoprostol (free acid) | 5 mg | 2464 |
| Cayman2015 | 13821 | Misoprostol (free acid) | 50 mg | 17752 |
| Cayman2015 | 13823 | AX 048 | 1 mg | 3332 |
| Cayman2015 | 13823 | AX 048 | 5 mg | 13132 |
| Cayman2015 | 13823 | AX 048 | 500 μg | 1750 |
| Cayman2015 | 13824 | JWH 018-d9 (exempt preparation) | 1 mg | 1736 |
| Cayman2015 | 13824 | JWH 018-d9 (exempt preparation) | 500 μg | 910 |
| Cayman2015 | 13825 | 11β-Misoprostol | 1 mg | 3808 |
| Cayman2015 | 13825 | 11β-Misoprostol | 500 μg | 2002 |
| Cayman2015 | 13828 | 3-Deazaneplanocin A | 1 mg | 2030 |
| Cayman2015 | 13828 | 3-Deazaneplanocin A | 10 mg | 9520 |
| Cayman2015 | 13828 | 3-Deazaneplanocin A | 5 mg | 7742 |
| Cayman2015 | 13828 | 3-Deazaneplanocin A | 500 μg | 1190 |
| Cayman2015 | 13829 | Sinefungin | 1 mg | 980 |
| Cayman2015 | 13829 | Sinefungin | 5 mg | 3766 |
| Cayman2015 | 13829 | Sinefungin | 500 μg | 546 |
| Cayman2015 | 13831 | Entecavir (hydrate) | 10 mg | 1302 |
| Cayman2015 | 13831 | Entecavir (hydrate) | 100 mg | 5488 |
| Cayman2015 | 13831 | Entecavir (hydrate) | 5 mg | 686 |
| Cayman2015 | 13831 | Entecavir (hydrate) | 50 mg | 3094 |
| Cayman2015 | 13832 | Resveratrol 3-O-D-Glucuronide | 1 mg | 7300 |
| Cayman2015 | 13832 | Resveratrol 3-O-D-Glucuronide | 2.5 mg | 17200 |
| Cayman2015 | 13832 | Resveratrol 3-O-D-Glucuronide | 5 mg | 32540 |
| Cayman2015 | 13833 | Resveratrol 4'-O-D-Glucuronide | 1 mg | 7300 |
| Cayman2015 | 13833 | Resveratrol 4'-O-D-Glucuronide | 2.5 mg | 17400 |
| Cayman2015 | 13833 | Resveratrol 4'-O-D-Glucuronide | 5 mg | 32500 |
| Cayman2015 | 13836 | CAY10625 | 1 mg | 924 |
| Cayman2015 | 13836 | CAY10625 | 10 mg | 7392 |
| Cayman2015 | 13836 | CAY10625 | 5 mg | 4158 |
| Cayman2015 | 13838 | CAY10626 | 1 mg | 1176 |
| Cayman2015 | 13838 | CAY10626 | 10 mg | 9408 |
| Cayman2015 | 13838 | CAY10626 | 25 mg | 20580 |
| Cayman2015 | 13838 | CAY10626 | 5 mg | 5292 |
| Cayman2015 | 13840 | 4-Methylbenzylidene camphor | 1 g | 1372 |
| Cayman2015 | 13840 | 4-Methylbenzylidene camphor | 10 g | 10976 |
| Cayman2015 | 13840 | 4-Methylbenzylidene camphor | 5 g | 6174 |
| Cayman2015 | 13841 | GANT 61 | 10 mg | 1736 |
| Cayman2015 | 13841 | GANT 61 | 100 mg | 12740 |
| Cayman2015 | 13841 | GANT 61 | 5 mg | 910 |
| Cayman2015 | 13841 | GANT 61 | 50 mg | 7280 |
| Cayman2015 | 13843 | IRAK-1 Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 13845 | IRAK-4 Polyclonal Antibody | 1 ea | 3612 |
| Cayman2015 | 13849 | Cyclophosphamide (hydrate) | 1 g | 350 |
| Cayman2015 | 13849 | Cyclophosphamide (hydrate) | 10 g | 1736 |
| Cayman2015 | 13849 | Cyclophosphamide (hydrate) | 25 g | 4102 |
| Cayman2015 | 13849 | Cyclophosphamide (hydrate) | 5 g | 910 |
| Cayman2015 | 13851 | Decoyinine | 1 mg | 270 |
| Cayman2015 | 13851 | Decoyinine | 5 mg | 1080 |
| Cayman2015 | 13852 | DL-AP3 | 100 mg | 672 |
| Cayman2015 | 13852 | DL-AP3 | 50 mg | 350 |
| Cayman2015 | 13853 | Ganciclovir | 100 mg | 1568 |
| Cayman2015 | 13853 | Ganciclovir | 250 mg | 3724 |
| Cayman2015 | 13853 | Ganciclovir | 50 mg | 826 |
| Cayman2015 | 13854 | Lopinavir | 100 mg | 1218 |
| Cayman2015 | 13854 | Lopinavir | 25 mg | 406 |
| Cayman2015 | 13854 | Lopinavir | 250 mg | 2352 |
| Cayman2015 | 13854 | Lopinavir | 50 mg | 686 |
| Cayman2015 | 13855 | NFAT Inhibitor | 1 mg | 896 |
| Cayman2015 | 13855 | NFAT Inhibitor | 10 mg | 7168 |
| Cayman2015 | 13855 | NFAT Inhibitor | 5 mg | 4032 |
| Cayman2015 | 13856 | 5-Nitroso-8-quinolinol | 10 mg | 406 |
| Cayman2015 | 13856 | 5-Nitroso-8-quinolinol | 100 mg | 2436 |
| Cayman2015 | 13856 | 5-Nitroso-8-quinolinol | 50 mg | 1316 |
| Cayman2015 | 13857 | Nocodazole | 10 mg | 812 |
| Cayman2015 | 13857 | Nocodazole | 100 mg | 4480 |
| Cayman2015 | 13857 | Nocodazole | 5 mg | 448 |
| Cayman2015 | 13857 | Nocodazole | 50 mg | 2688 |
| Cayman2015 | 13858 | NVP-231 | 1 mg | 350 |
| Cayman2015 | 13858 | NVP-231 | 10 mg | 1932 |
| Cayman2015 | 13858 | NVP-231 | 5 mg | 1050 |
| Cayman2015 | 13859 | PD 150606 | 25 mg | 4590 |
| Cayman2015 | 13859 | PD 150606 | 5 mg | 1020 |
| Cayman2015 | 13860 | N-(Benzoyloxy)succinimide | 1 g | 420 |
| Cayman2015 | 13860 | N-(Benzoyloxy)succinimide | 5 g | 1260 |
| Cayman2015 | 13861 | FMOC-Succinimide | 25 g | 1582 |
| Cayman2015 | 13861 | FMOC-Succinimide | 5 g | 350 |
| Cayman2015 | 13863 | Methylpiperidino pyrazole | 10 mg | 1736 |
| Cayman2015 | 13863 | Methylpiperidino pyrazole | 5 mg | 910 |
| Cayman2015 | 13863 | Methylpiperidino pyrazole | 50 mg | 7280 |
| Cayman2015 | 13864 | KN-93 (hydrochloride) | 1 mg | 1204 |
| Cayman2015 | 13864 | KN-93 (hydrochloride) | 10 mg | 9632 |
| Cayman2015 | 13864 | KN-93 (hydrochloride) | 5 mg | 5418 |
| Cayman2015 | 13866 | PRMT6 (human recombinant; baculovirus expressed) | 100 μg | 3976 |
| Cayman2015 | 13866 | PRMT6 (human recombinant; baculovirus expressed) | 25 μg | 1106 |
| Cayman2015 | 13866 | PRMT6 (human recombinant; baculovirus expressed) | 50 μg | 2100 |
| Cayman2015 | 13868 | Cathine | 10 mg | 1302 |
| Cayman2015 | 13868 | Cathine | 5 mg | 686 |
| Cayman2015 | 13868 | Cathine | 50 mg | 5488 |
| Cayman2015 | 13869 | (-)-(S)-Cathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 13869 | (-)-(S)-Cathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 13869 | (-)-(S)-Cathinone (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 13870 | Pyroxamide | 10 mg | 1204 |
| Cayman2015 | 13870 | Pyroxamide | 25 mg | 2856 |
| Cayman2015 | 13870 | Pyroxamide | 5 mg | 672 |
| Cayman2015 | 13870 | Pyroxamide | 50 mg | 4704 |
| Cayman2015 | 13872 | Ritonavir | 10 mg | 616 |
| Cayman2015 | 13872 | Ritonavir | 100 mg | 4928 |
| Cayman2015 | 13872 | Ritonavir | 50 mg | 2618 |
| Cayman2015 | 13873 | SU 6668 | 1 mg | 336 |
| Cayman2015 | 13873 | SU 6668 | 10 mg | 1386 |
| Cayman2015 | 13873 | SU 6668 | 5 mg | 826 |
| Cayman2015 | 13874 | Tenofovir | 10 mg | 1638 |
| Cayman2015 | 13874 | Tenofovir | 100 mg | 10920 |
| Cayman2015 | 13874 | Tenofovir | 5 mg | 910 |
| Cayman2015 | 13874 | Tenofovir | 50 mg | 7280 |
| Cayman2015 | 13875 | Valganciclovir (hydrochloride) | 10 mg | 686 |
| Cayman2015 | 13875 | Valganciclovir (hydrochloride) | 100 mg | 3430 |
| Cayman2015 | 13875 | Valganciclovir (hydrochloride) | 25 mg | 1204 |
| Cayman2015 | 13875 | Valganciclovir (hydrochloride) | 50 mg | 1890 |
| Cayman2015 | 13876 | Alexidine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 13876 | Alexidine (hydrochloride) | 25 mg | 700 |
| Cayman2015 | 13876 | Alexidine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 13877 | Bleomycin (sulfate) | 1 mg | 560 |
| Cayman2015 | 13877 | Bleomycin (sulfate) | 10 mg | 1848 |
| Cayman2015 | 13877 | Bleomycin (sulfate) | 5 mg | 1372 |
| Cayman2015 | 13877 | Bleomycin (sulfate) | 50 mg | 6160 |
| Cayman2015 | 13878 | KL001 | 10 mg | 1330 |
| Cayman2015 | 13878 | KL001 | 25 mg | 2450 |
| Cayman2015 | 13878 | KL001 | 5 mg | 700 |
| Cayman2015 | 13879 | KL002 | 10 mg | 1330 |
| Cayman2015 | 13879 | KL002 | 25 mg | 2450 |
| Cayman2015 | 13879 | KL002 | 5 mg | 700 |
| Cayman2015 | 13883 | Prostaglandin F2α-1-glyceryl ester-d5 | 100 μg | 2058 |
| Cayman2015 | 13883 | Prostaglandin F2α-1-glyceryl ester-d5 | 25 μg | 686 |
| Cayman2015 | 13883 | Prostaglandin F2α-1-glyceryl ester-d5 | 50 μg | 1092 |
| Cayman2015 | 13883 | Prostaglandin F2α-1-glyceryl ester-d5 | 500 μg | 8918 |
| Cayman2015 | 13884 | Puromycin (hydrochloride) | 100 mg | 952 |
| Cayman2015 | 13884 | Puromycin (hydrochloride) | 25 mg | 266 |
| Cayman2015 | 13884 | Puromycin (hydrochloride) | 50 mg | 504 |
| Cayman2015 | 13884 | Puromycin (hydrochloride) | 500 mg | 2660 |
| Cayman2015 | 13885 | DOI (hydrochloride) | 10 mg | 1232 |
| Cayman2015 | 13885 | DOI (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 13885 | DOI (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 13886 | 4-methyl-α-Ethyltryptamine | 10 mg | 952 |
| Cayman2015 | 13886 | 4-methyl-α-Ethyltryptamine | 25 mg | 2310 |
| Cayman2015 | 13886 | 4-methyl-α-Ethyltryptamine | 5 mg | 616 |
| Cayman2015 | 13887 | 3,4,5-Trimethoxyamphetamine (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 13887 | 3,4,5-Trimethoxyamphetamine (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 13887 | 3,4,5-Trimethoxyamphetamine (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 13889 | JWH 018 N-(4-oxo-pentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 13889 | JWH 018 N-(4-oxo-pentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 13889 | JWH 018 N-(4-oxo-pentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 13890 | JWH 071 | 1 mg | 490 |
| Cayman2015 | 13890 | JWH 071 | 10 mg | 3500 |
| Cayman2015 | 13890 | JWH 071 | 25 mg | 6930 |
| Cayman2015 | 13890 | JWH 071 | 5 mg | 1960 |
| Cayman2015 | 13891 | (S)-nitro-Blebbistatin | 1 mg | 1330 |
| Cayman2015 | 13891 | (S)-nitro-Blebbistatin | 10 mg | 8386 |
| Cayman2015 | 13891 | (S)-nitro-Blebbistatin | 25 mg | 13972 |
| Cayman2015 | 13891 | (S)-nitro-Blebbistatin | 5 mg | 5320 |
| Cayman2015 | 13892 | Piperonyl methyl ketone | 10 mg | 1302 |
| Cayman2015 | 13892 | Piperonyl methyl ketone | 5 mg | 686 |
| Cayman2015 | 13892 | Piperonyl methyl ketone | 50 mg | 3094 |
| Cayman2015 | 13893 | 4-CAB (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 13893 | 4-CAB (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 13893 | 4-CAB (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 13894 | Safrole | 10 mg | 1050 |
| Cayman2015 | 13894 | Safrole | 25 mg | 1974 |
| Cayman2015 | 13894 | Safrole | 50 mg | 3682 |
| Cayman2015 | 13895 | MMAI (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 13895 | MMAI (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 13895 | MMAI (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 13896 | (±)-Ethylphenidate (hydrochloride) | 10 mg | 1736 |
| Cayman2015 | 13896 | (±)-Ethylphenidate (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 13896 | (±)-Ethylphenidate (hydrochloride) | 50 mg | 7280 |
| Cayman2015 | 13897 | Phenylpiracetam | 1 mg | 686 |
| Cayman2015 | 13897 | Phenylpiracetam | 10 mg | 5488 |
| Cayman2015 | 13897 | Phenylpiracetam | 5 mg | 3094 |
| Cayman2015 | 13898 | A-836339 | 1 mg | 910 |
| Cayman2015 | 13898 | A-836339 | 10 mg | 7280 |
| Cayman2015 | 13898 | A-836339 | 5 mg | 4102 |
| Cayman2015 | 13899 | 5-APDI (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 13899 | 5-APDI (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 13899 | 5-APDI (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 13907 | Caspase-1 Monoclonal Antibody (Clone 14F468) | 1 ea | 3990 |
| Cayman2015 | 13909 | Caspase-3 Monoclonal Antibody (Clone 31A1067) | 1 ea | 4144 |
| Cayman2015 | 13910 | 19(R)-hydroxy Prostaglandin E1 | 100 μg | 1204 |
| Cayman2015 | 13910 | 19(R)-hydroxy Prostaglandin E1 | 50 μg | 630 |
| Cayman2015 | 13910 | 19(R)-hydroxy Prostaglandin E1 | 500 μg | 5040 |
| Cayman2015 | 13911 | Caspase-3 Monoclonal Antibody (Clone 31A893) | 1 ea | 3864 |
| Cayman2015 | 13913 | Caspase-8 Monoclonal Antibody (Clone 90A992) | 1 ea | 4032 |
| Cayman2015 | 13915 | Caspase-9 (carboxy-terminal divergent) Polyclonal Antibody | 1 ea | 3374 |
| Cayman2015 | 13916 | Caspase-14 Monoclonal Antibody (Clone 70A1426) | 1 ea | 3864 |
| Cayman2015 | 13920 | 15(R),19(R)-hydroxy Prostaglandin E1 | 100 μg | 770 |
| Cayman2015 | 13920 | 15(R),19(R)-hydroxy Prostaglandin E1 | 50 μg | 406 |
| Cayman2015 | 13920 | 15(R),19(R)-hydroxy Prostaglandin E1 | 500 μg | 3248 |
| Cayman2015 | 13923 | IκBα (Phospho-Ser32/36) Monoclonal Antibody (Clone 39A1413) | 1 ea | 4130 |
| Cayman2015 | 13926 | IκBζ Polyclonal Antibody | 1 ea | 3570 |
| Cayman2015 | 13931 | IKKγ Monoclonal Antibody (Clone 72C627) | 1 ea | 3864 |
| Cayman2015 | 13938 | 6-IT | 1 mg | 686 |
| Cayman2015 | 13938 | 6-IT | 10 mg | 5488 |
| Cayman2015 | 13938 | 6-IT | 5 mg | 3094 |
| Cayman2015 | 13939 | Thiosildenafil | 1 mg | 476 |
| Cayman2015 | 13939 | Thiosildenafil | 10 mg | 3332 |
| Cayman2015 | 13939 | Thiosildenafil | 5 mg | 2142 |
| Cayman2015 | 13940 | Nervonic Acid | 100 mg | 490 |
| Cayman2015 | 13940 | Nervonic Acid | 250 mg | 1162 |
| Cayman2015 | 13940 | Nervonic Acid | 500 mg | 2212 |
| Cayman2015 | 13942 | ML-265 | 1 mg | 490 |
| Cayman2015 | 13942 | ML-265 | 10 mg | 2212 |
| Cayman2015 | 13942 | ML-265 | 25 mg | 4284 |
| Cayman2015 | 13942 | ML-265 | 5 mg | 1344 |
| Cayman2015 | 13944 | N-Oxalylglycine | 10 mg | 490 |
| Cayman2015 | 13944 | N-Oxalylglycine | 100 mg | 2464 |
| Cayman2015 | 13944 | N-Oxalylglycine | 5 mg | 280 |
| Cayman2015 | 13944 | N-Oxalylglycine | 50 mg | 1540 |
| Cayman2015 | 13945 | WDR5-0103 | 1 mg | 686 |
| Cayman2015 | 13945 | WDR5-0103 | 10 mg | 5488 |
| Cayman2015 | 13945 | WDR5-0103 | 25 mg | 12012 |
| Cayman2015 | 13945 | WDR5-0103 | 5 mg | 3094 |
| Cayman2015 | 13949 | 1-(3-Chlorophenyl) piperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 13949 | 1-(3-Chlorophenyl) piperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 13949 | 1-(3-Chlorophenyl) piperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 13950 | Dextromethorphan (hydrobromide hydrate) | 100 mg | 672 |
| Cayman2015 | 13950 | Dextromethorphan (hydrobromide hydrate) | 50 mg | 350 |
| Cayman2015 | 13950 | Dextromethorphan (hydrobromide hydrate) | 500 mg | 2786 |
| Cayman2015 | 13951 | IWP-2 | 1 mg | 350 |
| Cayman2015 | 13951 | IWP-2 | 10 mg | 1932 |
| Cayman2015 | 13951 | IWP-2 | 25 mg | 4340 |
| Cayman2015 | 13951 | IWP-2 | 5 mg | 1134 |
| Cayman2015 | 13952 | IWP-2-V2 | 1 mg | 420 |
| Cayman2015 | 13952 | IWP-2-V2 | 10 mg | 3780 |
| Cayman2015 | 13952 | IWP-2-V2 | 25 mg | 7882 |
| Cayman2015 | 13952 | IWP-2-V2 | 5 mg | 2002 |
| Cayman2015 | 13953 | IWP-3 | 1 mg | 420 |
| Cayman2015 | 13953 | IWP-3 | 10 mg | 2520 |
| Cayman2015 | 13953 | IWP-3 | 25 mg | 5460 |
| Cayman2015 | 13953 | IWP-3 | 5 mg | 1372 |
| Cayman2015 | 13954 | IWP-4 | 1 mg | 420 |
| Cayman2015 | 13954 | IWP-4 | 10 mg | 3780 |
| Cayman2015 | 13954 | IWP-4 | 25 mg | 7882 |
| Cayman2015 | 13954 | IWP-4 | 5 mg | 2002 |
| Cayman2015 | 13955 | Lagochiline | 100 mg | 3472 |
| Cayman2015 | 13955 | Lagochiline | 25 mg | 966 |
| Cayman2015 | 13955 | Lagochiline | 50 mg | 1834 |
| Cayman2015 | 13956 | S-(5'-Adenosyl)-L-methionine chloride (hydrochloride) | 1 mg | 462 |
| Cayman2015 | 13956 | S-(5'-Adenosyl)-L-methionine chloride (hydrochloride) | 2.5 mg | 1022 |
| Cayman2015 | 13956 | S-(5'-Adenosyl)-L-methionine chloride (hydrochloride) | 5 mg | 1820 |
| Cayman2015 | 13957 | 2C-T (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 13957 | 2C-T (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 13957 | 2C-T (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 13958 | N-hydroxy MDA (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 13958 | N-hydroxy MDA (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 13958 | N-hydroxy MDA (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 13959 | N,N-DMT | 10 mg | 490 |
| Cayman2015 | 13959 | N,N-DMT | 25 mg | 700 |
| Cayman2015 | 13959 | N,N-DMT | 5 mg | 350 |
| Cayman2015 | 13960 | Methotrexate | 100 mg | 476 |
| Cayman2015 | 13960 | Methotrexate | 250 mg | 1134 |
| Cayman2015 | 13960 | Methotrexate | 50 mg | 252 |
| Cayman2015 | 13960 | Methotrexate | 500 mg | 2016 |
| Cayman2015 | 13962 | Carisoprodol | 10 mg | 420 |
| Cayman2015 | 13962 | Carisoprodol | 100 mg | 1330 |
| Cayman2015 | 13962 | Carisoprodol | 50 mg | 840 |
| Cayman2015 | 13963 | 3C-B-fly (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 13963 | 3C-B-fly (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 13963 | 3C-B-fly (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 13964 | LY333531 (hydrochloride) | 1 mg | 1275 |
| Cayman2015 | 13964 | LY333531 (hydrochloride) | 5 mg | 4785 |
| Cayman2015 | 13965 | AMI-1 (sodium salt) | 25 mg | 4725 |
| Cayman2015 | 13965 | AMI-1 (sodium salt) | 5 mg | 1125 |
| Cayman2015 | 13966 | EPZ005687 | 10 mg | 4424 |
| Cayman2015 | 13966 | EPZ005687 | 25 mg | 6692 |
| Cayman2015 | 13966 | EPZ005687 | 5 mg | 910 |
| Cayman2015 | 13966 | EPZ005687 | 50 mg | 9282 |
| Cayman2015 | 13967 | SGC0946 | 10 mg | 2856 |
| Cayman2015 | 13967 | SGC0946 | 5 mg | 1722 |
| Cayman2015 | 13967 | SGC0946 | 50 mg | 10682 |
| Cayman2015 | 13968 | UNC1215 | 1 mg | 532 |
| Cayman2015 | 13968 | UNC1215 | 10 mg | 2352 |
| Cayman2015 | 13968 | UNC1215 | 5 mg | 1512 |
| Cayman2015 | 13968 | UNC1215 | 50 mg | 10920 |
| Cayman2015 | 13969 | 2,3-MDA (hydrochloride) | 10 mg | 742 |
| Cayman2015 | 13969 | 2,3-MDA (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 13969 | 2,3-MDA (hydrochloride) | 50 mg | 2940 |
| Cayman2015 | 13970 | 2,3-MDMA (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 13970 | 2,3-MDMA (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 13970 | 2,3-MDMA (hydrochloride) | 50 mg | 3248 |
| Cayman2015 | 13971 | 3,4-MDMA (hydrochloride) | 10 mg | 672 |
| Cayman2015 | 13971 | 3,4-MDMA (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 13971 | 3,4-MDMA (hydrochloride) | 50 mg | 2632 |
| Cayman2015 | 13972 | 3,4-MDPA (hydrochloride) | 10 mg | 700 |
| Cayman2015 | 13972 | 3,4-MDPA (hydrochloride) | 5 mg | 392 |
| Cayman2015 | 13972 | 3,4-MDPA (hydrochloride) | 50 mg | 3136 |
| Cayman2015 | 13975 | AD57 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 13975 | AD57 (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 13975 | AD57 (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 13977 | JWH 116 | 1 mg | 490 |
| Cayman2015 | 13977 | JWH 116 | 10 mg | 3500 |
| Cayman2015 | 13977 | JWH 116 | 25 mg | 6930 |
| Cayman2015 | 13977 | JWH 116 | 5 mg | 1960 |
| Cayman2015 | 13978 | JWH 149 | 1 mg | 490 |
| Cayman2015 | 13978 | JWH 149 | 10 mg | 3500 |
| Cayman2015 | 13978 | JWH 149 | 25 mg | 6930 |
| Cayman2015 | 13978 | JWH 149 | 5 mg | 1960 |
| Cayman2015 | 13979 | JWH 167 | 10 mg | 1484 |
| Cayman2015 | 13979 | JWH 167 | 25 mg | 3528 |
| Cayman2015 | 13979 | JWH 167 | 5 mg | 784 |
| Cayman2015 | 13980 | JWH 193 | 10 mg | 1484 |
| Cayman2015 | 13980 | JWH 193 | 25 mg | 3528 |
| Cayman2015 | 13980 | JWH 193 | 5 mg | 784 |
| Cayman2015 | 13981 | JWH 198 | 10 mg | 1484 |
| Cayman2015 | 13981 | JWH 198 | 25 mg | 3528 |
| Cayman2015 | 13981 | JWH 198 | 5 mg | 784 |
| Cayman2015 | 13986 | Pirfenidone | 10 mg | 882 |
| Cayman2015 | 13986 | Pirfenidone | 100 mg | 4158 |
| Cayman2015 | 13986 | Pirfenidone | 5 mg | 462 |
| Cayman2015 | 13986 | Pirfenidone | 50 mg | 3010 |
| Cayman2015 | 13987 | Azathioprine | 1 g | 882 |
| Cayman2015 | 13987 | Azathioprine | 500 mg | 462 |
| Cayman2015 | 13988 | Mycophenolate Mofetil | 100 mg | 952 |
| Cayman2015 | 13988 | Mycophenolate Mofetil | 250 mg | 2268 |
| Cayman2015 | 13988 | Mycophenolate Mofetil | 50 mg | 504 |
| Cayman2015 | 13988 | Mycophenolate Mofetil | 500 mg | 4032 |
| Cayman2015 | 13992 | 17-phenyl trinor Prostaglandin F2α 1,15-lactone | 1 mg | 728 |
| Cayman2015 | 13992 | 17-phenyl trinor Prostaglandin F2α 1,15-lactone | 10 mg | 5684 |
| Cayman2015 | 13992 | 17-phenyl trinor Prostaglandin F2α 1,15-lactone | 5 mg | 3248 |
| Cayman2015 | 13992 | 17-phenyl trinor Prostaglandin F2α 1,15-lactone | 500 μg | 406 |
| Cayman2015 | 13995 | Rotenone | 1 g | 686 |
| Cayman2015 | 13995 | Rotenone | 10 g | 2408 |
| Cayman2015 | 13995 | Rotenone | 25 g | 5152 |
| Cayman2015 | 13995 | Rotenone | 5 g | 1372 |
| Cayman2015 | 13997 | (+)-Methamphetamine (hydrochloride) | 10 mg | 406 |
| Cayman2015 | 13997 | (+)-Methamphetamine (hydrochloride) | 50 mg | 812 |
| Cayman2015 | 13999 | Cafestol | 10 mg | 700 |
| Cayman2015 | 13999 | Cafestol | 5 mg | 490 |
| Cayman2015 | 13999 | Cafestol | 50 mg | 2100 |
| Cayman2015 | 14000 | Auraptene | 10 mg | 448 |
| Cayman2015 | 14000 | Auraptene | 25 mg | 966 |
| Cayman2015 | 14000 | Auraptene | 5 mg | 308 |
| Cayman2015 | 14000 | Auraptene | 50 mg | 1750 |
| Cayman2015 | 14001 | (±)-Alliin | 10 mg | 1736 |
| Cayman2015 | 14001 | (±)-Alliin | 5 mg | 910 |
| Cayman2015 | 14001 | (±)-Alliin | 50 mg | 7280 |
| Cayman2015 | 14002 | (+)-Alliin | 1 mg | 420 |
| Cayman2015 | 14002 | (+)-Alliin | 10 mg | 3346 |
| Cayman2015 | 14002 | (+)-Alliin | 5 mg | 1890 |
| Cayman2015 | 14003 | Acivicin | 1 mg | 350 |
| Cayman2015 | 14003 | Acivicin | 10 mg | 1722 |
| Cayman2015 | 14003 | Acivicin | 5 mg | 1316 |
| Cayman2015 | 14004 | AK-7 | 10 mg | 1568 |
| Cayman2015 | 14004 | AK-7 | 25 mg | 3724 |
| Cayman2015 | 14004 | AK-7 | 5 mg | 826 |
| Cayman2015 | 14004 | AK-7 | 50 mg | 6608 |
| Cayman2015 | 14005 | Bafilomycin B1 | 1 mg | 2070 |
| Cayman2015 | 14005 | Bafilomycin B1 | 100 μg | 675 |
| Cayman2015 | 14005 | Bafilomycin B1 | 5 mg | 6900 |
| Cayman2015 | 14006 | (R)-CR8 | 1 mg | 825 |
| Cayman2015 | 14006 | (R)-CR8 | 5 mg | 2475 |
| Cayman2015 | 14007 | (+)-Aphidicolin | 1 mg | 975 |
| Cayman2015 | 14007 | (+)-Aphidicolin | 25 mg | 10965 |
| Cayman2015 | 14007 | (+)-Aphidicolin | 5 mg | 3900 |
| Cayman2015 | 14008 | Sildenafil Citrate | 10 mg | 560 |
| Cayman2015 | 14008 | Sildenafil Citrate | 25 mg | 910 |
| Cayman2015 | 14008 | Sildenafil Citrate | 50 mg | 1512 |
| Cayman2015 | 14010 | Prostaglandin E2 | 1 mg | 266 |
| Cayman2015 | 14010 | Prostaglandin E2 | 10 mg | 1330 |
| Cayman2015 | 14010 | Prostaglandin E2 | 5 mg | 938 |
| Cayman2015 | 14010 | Prostaglandin E2 | 50 mg | 5992 |
| Cayman2015 | 14011 | Prostaglandin E2 methyl ester | 1 mg | 672 |
| Cayman2015 | 14011 | Prostaglandin E2 methyl ester | 10 mg | 4900 |
| Cayman2015 | 14011 | Prostaglandin E2 methyl ester | 5 mg | 2800 |
| Cayman2015 | 14011 | Prostaglandin E2 methyl ester | 500 μg | 350 |
| Cayman2015 | 14012 | Prostaglandin E2 Ethanolamide | 1 mg | 686 |
| Cayman2015 | 14012 | Prostaglandin E2 Ethanolamide | 10 mg | 5096 |
| Cayman2015 | 14012 | Prostaglandin E2 Ethanolamide | 5 mg | 2912 |
| Cayman2015 | 14012 | Prostaglandin E2 Ethanolamide | 500 μg | 364 |
| Cayman2015 | 14013 | JWH 080 | 10 mg | 1484 |
| Cayman2015 | 14013 | JWH 080 | 25 mg | 3528 |
| Cayman2015 | 14013 | JWH 080 | 5 mg | 784 |
| Cayman2015 | 14014 | L-Deoxyalliin | 10 mg | 490 |
| Cayman2015 | 14014 | L-Deoxyalliin | 100 mg | 3920 |
| Cayman2015 | 14014 | L-Deoxyalliin | 50 mg | 2212 |
| Cayman2015 | 14015 | Kahweol | 10 mg | 1386 |
| Cayman2015 | 14015 | Kahweol | 25 mg | 3276 |
| Cayman2015 | 14015 | Kahweol | 5 mg | 728 |
| Cayman2015 | 14016 | Iberin | 1 mg | 350 |
| Cayman2015 | 14016 | Iberin | 10 mg | 2100 |
| Cayman2015 | 14016 | Iberin | 5 mg | 1400 |
| Cayman2015 | 14017 | Erucin | 10 mg | 686 |
| Cayman2015 | 14017 | Erucin | 25 mg | 1372 |
| Cayman2015 | 14017 | Erucin | 50 mg | 2646 |
| Cayman2015 | 14018 | WIN 18,446 | 100 mg | 1232 |
| Cayman2015 | 14018 | WIN 18,446 | 250 mg | 1722 |
| Cayman2015 | 14018 | WIN 18,446 | 50 mg | 686 |
| Cayman2015 | 14020 | 1-(4-Methoxyphenyl) piperazine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 14020 | 1-(4-Methoxyphenyl) piperazine (hydrochloride) | 100 mg | 2016 |
| Cayman2015 | 14020 | 1-(4-Methoxyphenyl) piperazine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 14024 | Tadalafil | 10 mg | 490 |
| Cayman2015 | 14024 | Tadalafil | 100 mg | 2212 |
| Cayman2015 | 14024 | Tadalafil | 25 mg | 924 |
| Cayman2015 | 14024 | Tadalafil | 50 mg | 1470 |
| Cayman2015 | 14026 | Leupeptin (hemisulfate) | 10 mg | 686 |
| Cayman2015 | 14026 | Leupeptin (hemisulfate) | 100 mg | 4466 |
| Cayman2015 | 14026 | Leupeptin (hemisulfate) | 25 mg | 1288 |
| Cayman2015 | 14026 | Leupeptin (hemisulfate) | 50 mg | 2408 |
| Cayman2015 | 14028 | Cannabidiolic Acid | 1 mg | 1568 |
| Cayman2015 | 14028 | Cannabidiolic Acid | 10 mg | 12544 |
| Cayman2015 | 14028 | Cannabidiolic Acid | 5 mg | 7056 |
| Cayman2015 | 14029 | Prostaglandin E2-d4-1-glyceryl ester | 100 μg | 2100 |
| Cayman2015 | 14029 | Prostaglandin E2-d4-1-glyceryl ester | 50 μg | 1106 |
| Cayman2015 | 14029 | Prostaglandin E2-d4-1-glyceryl ester | 500 μg | 8848 |
| Cayman2015 | 14031 | Ingenol | 1 mg | 560 |
| Cayman2015 | 14031 | Ingenol | 10 mg | 3850 |
| Cayman2015 | 14031 | Ingenol | 5 mg | 2450 |
| Cayman2015 | 14031 | Ingenol | 500 μg | 350 |
| Cayman2015 | 14033 | GPR31 (N-Term) Polyclonal Antibody | 1 ea | 3850 |
| Cayman2015 | 14035 | 3-Bromomethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14035 | 3-Bromomethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14035 | 3-Bromomethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14038 | AB-PINACA | 10 mg | 2310 |
| Cayman2015 | 14038 | AB-PINACA | 25 mg | 4620 |
| Cayman2015 | 14038 | AB-PINACA | 50 mg | 6930 |
| Cayman2015 | 14039 | AB-FUBINACA | 10 mg | 2310 |
| Cayman2015 | 14039 | AB-FUBINACA | 25 mg | 4620 |
| Cayman2015 | 14039 | AB-FUBINACA | 50 mg | 6930 |
| Cayman2015 | 14042 | Δ8-THC | 10 mg | 938 |
| Cayman2015 | 14042 | Δ8-THC | 5 mg | 490 |
| Cayman2015 | 14042 | Δ8-THC | 50 mg | 3682 |
| Cayman2015 | 14044 | Pinostilbene | 1 mg | 238 |
| Cayman2015 | 14044 | Pinostilbene | 10 mg | 1904 |
| Cayman2015 | 14044 | Pinostilbene | 25 mg | 4172 |
| Cayman2015 | 14044 | Pinostilbene | 5 mg | 1078 |
| Cayman2015 | 14046 | KLH Polyclonal Antibody | 1 ea | 2730 |
| Cayman2015 | 14049 | STK393606 | 1 mg | 630 |
| Cayman2015 | 14049 | STK393606 | 10 mg | 4732 |
| Cayman2015 | 14049 | STK393606 | 25 mg | 11032 |
| Cayman2015 | 14049 | STK393606 | 5 mg | 2520 |
| Cayman2015 | 14050 | AH 6809 | 1 mg | 196 |
| Cayman2015 | 14050 | AH 6809 | 10 mg | 1568 |
| Cayman2015 | 14050 | AH 6809 | 5 mg | 882 |
| Cayman2015 | 14050 | AH 6809 | 50 mg | 6860 |
| Cayman2015 | 14051 | Coumarin Boronic Acid | 10 mg | 1610 |
| Cayman2015 | 14051 | Coumarin Boronic Acid | 100 mg | 12880 |
| Cayman2015 | 14051 | Coumarin Boronic Acid | 50 mg | 7252 |
| Cayman2015 | 14053 | Prostaglandin E2 p-acetamidophenyl ester | 1 mg | 588 |
| Cayman2015 | 14053 | Prostaglandin E2 p-acetamidophenyl ester | 10 mg | 4704 |
| Cayman2015 | 14053 | Prostaglandin E2 p-acetamidophenyl ester | 5 mg | 2646 |
| Cayman2015 | 14054 | Prostaglandin E2 p-benzamidophenyl ester | 1 mg | 588 |
| Cayman2015 | 14054 | Prostaglandin E2 p-benzamidophenyl ester | 10 mg | 4704 |
| Cayman2015 | 14054 | Prostaglandin E2 p-benzamidophenyl ester | 5 mg | 2646 |
| Cayman2015 | 14055 | XLR11 Degradant | 1 mg | 1330 |
| Cayman2015 | 14055 | XLR11 Degradant | 10 mg | 6650 |
| Cayman2015 | 14055 | XLR11 Degradant | 5 mg | 3654 |
| Cayman2015 | 14056 | 4-acetoxy DMT (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 14056 | 4-acetoxy DMT (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 14056 | 4-acetoxy DMT (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 14057 | WIKI4 | 10 mg | 1890 |
| Cayman2015 | 14057 | WIKI4 | 25 mg | 4466 |
| Cayman2015 | 14057 | WIKI4 | 5 mg | 1050 |
| Cayman2015 | 14057 | WIKI4 | 50 mg | 8400 |
| Cayman2015 | 14060 | SC-19220 | 1 mg | 210 |
| Cayman2015 | 14060 | SC-19220 | 10 mg | 1680 |
| Cayman2015 | 14060 | SC-19220 | 25 mg | 3682 |
| Cayman2015 | 14060 | SC-19220 | 5 mg | 952 |
| Cayman2015 | 14062 | Dynasore | 10 mg | 952 |
| Cayman2015 | 14062 | Dynasore | 25 mg | 2282 |
| Cayman2015 | 14062 | Dynasore | 5 mg | 532 |
| Cayman2015 | 14062 | Dynasore | 50 mg | 4368 |
| Cayman2015 | 14064 | 2C-G (hydrochloride) | 10 mg | 952 |
| Cayman2015 | 14064 | 2C-G (hydrochloride) | 5 mg | 616 |
| Cayman2015 | 14064 | 2C-G (hydrochloride) | 50 mg | 3696 |
| Cayman2015 | 14065 | 25G-NBOMe (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14065 | 25G-NBOMe (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14065 | 25G-NBOMe (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14066 | 25I-NBF (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14066 | 25I-NBF (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14066 | 25I-NBF (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14068 | AM1248 azepane isomer | 1 mg | 910 |
| Cayman2015 | 14068 | AM1248 azepane isomer | 10 mg | 7280 |
| Cayman2015 | 14068 | AM1248 azepane isomer | 5 mg | 4102 |
| Cayman2015 | 14069 | Propylthiouracil | 10 g | 350 |
| Cayman2015 | 14069 | Propylthiouracil | 100 g | 2240 |
| Cayman2015 | 14069 | Propylthiouracil | 25 g | 672 |
| Cayman2015 | 14069 | Propylthiouracil | 50 g | 1260 |
| Cayman2015 | 14070 | ONO-8711 | 1 mg | 1050 |
| Cayman2015 | 14070 | ONO-8711 | 10 mg | 6622 |
| Cayman2015 | 14070 | ONO-8711 | 25 mg | 11816 |
| Cayman2015 | 14070 | ONO-8711 | 5 mg | 4144 |
| Cayman2015 | 14072 | LGK974 | 1 mg | 770 |
| Cayman2015 | 14072 | LGK974 | 5 mg | 2240 |
| Cayman2015 | 14072 | LGK974 | 500 μg | 406 |
| Cayman2015 | 14073 | TP53BP1 tudor-like region (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14073 | TP53BP1 tudor-like region (human recombinant) | 25 μg | 1456 |
| Cayman2015 | 14073 | TP53BP1 tudor-like region (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14074 | Polymyxin B1 | 1 mg | 1372 |
| Cayman2015 | 14074 | Polymyxin B1 | 10 mg | 8750 |
| Cayman2015 | 14074 | Polymyxin B1 | 5 mg | 5488 |
| Cayman2015 | 14075 | Polymyxin B1 Isoleucine | 1 mg | 2604 |
| Cayman2015 | 14075 | Polymyxin B1 Isoleucine | 500 μg | 1372 |
| Cayman2015 | 14078 | 3,4-Methylenedioxy-5-methylethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14078 | 3,4-Methylenedioxy-5-methylethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14078 | 3,4-Methylenedioxy-5-methylethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14082 | MT-45 (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14082 | MT-45 (hydrochloride) | 10 mg | 2730 |
| Cayman2015 | 14082 | MT-45 (hydrochloride) | 5 mg | 1736 |
| Cayman2015 | 14083 | GPR31 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14084 | JWH 073 6-methoxyindole analog | 1 mg | 910 |
| Cayman2015 | 14084 | JWH 073 6-methoxyindole analog | 10 mg | 7280 |
| Cayman2015 | 14084 | JWH 073 6-methoxyindole analog | 5 mg | 4102 |
| Cayman2015 | 14085 | 3,4-MDEA (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 14085 | 3,4-MDEA (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 14085 | 3,4-MDEA (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 14093 | α-Pyrrolidinopentiophenone metabolite 1 (trifluoroacetate salt) | 1 mg | 1330 |
| Cayman2015 | 14093 | α-Pyrrolidinopentiophenone metabolite 1 (trifluoroacetate salt) | 10 mg | 4900 |
| Cayman2015 | 14093 | α-Pyrrolidinopentiophenone metabolite 1 (trifluoroacetate salt) | 5 mg | 3150 |
| Cayman2015 | 14094 | GSK 343 | 1 mg | 686 |
| Cayman2015 | 14094 | GSK 343 | 10 mg | 2058 |
| Cayman2015 | 14094 | GSK 343 | 25 mg | 3430 |
| Cayman2015 | 14094 | GSK 343 | 5 mg | 1204 |
| Cayman2015 | 14095 | 5-fluoro PB-22 | 10 mg | 1960 |
| Cayman2015 | 14095 | 5-fluoro PB-22 | 25 mg | 4172 |
| Cayman2015 | 14095 | 5-fluoro PB-22 | 50 mg | 7350 |
| Cayman2015 | 14096 | PB-22 | 10 mg | 1960 |
| Cayman2015 | 14096 | PB-22 | 25 mg | 4172 |
| Cayman2015 | 14096 | PB-22 | 50 mg | 7350 |
| Cayman2015 | 14097 | 4-methoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14097 | 4-methoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14097 | 4-methoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14099 | BB-22 | 10 mg | 1960 |
| Cayman2015 | 14099 | BB-22 | 25 mg | 4172 |
| Cayman2015 | 14099 | BB-22 | 50 mg | 7350 |
| Cayman2015 | 14100 | Δ4-Dafachronic Acid | 1 mg | 1330 |
| Cayman2015 | 14100 | Δ4-Dafachronic Acid | 10 mg | 10640 |
| Cayman2015 | 14100 | Δ4-Dafachronic Acid | 5 mg | 5992 |
| Cayman2015 | 14101 | (25S)-Δ7-Dafachronic Acid | 100 μg | 3375 |
| Cayman2015 | 14102 | OAC1 | 10 mg | 1834 |
| Cayman2015 | 14102 | OAC1 | 25 mg | 4102 |
| Cayman2015 | 14102 | OAC1 | 5 mg | 966 |
| Cayman2015 | 14103 | OAC2 | 10 mg | 938 |
| Cayman2015 | 14103 | OAC2 | 5 mg | 490 |
| Cayman2015 | 14103 | OAC2 | 50 mg | 3920 |
| Cayman2015 | 14104 | OAC3 | 10 mg | 938 |
| Cayman2015 | 14104 | OAC3 | 5 mg | 490 |
| Cayman2015 | 14104 | OAC3 | 50 mg | 3920 |
| Cayman2015 | 14105 | deschloro-N-ethyl-Ketamine (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 14105 | deschloro-N-ethyl-Ketamine (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 14105 | deschloro-N-ethyl-Ketamine (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 14106 | 3,4-dimethoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14106 | 3,4-dimethoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14106 | 3,4-dimethoxy-α-Pyrrolidinopentiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14107 | Escaline (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14107 | Escaline (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14107 | Escaline (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14109 | 5-MAPB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14109 | 5-MAPB (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 14109 | 5-MAPB (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 14110 | 6-MAPB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14110 | 6-MAPB (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 14110 | 6-MAPB (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 14111 | 5-MAPDB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14111 | 5-MAPDB (hydrochloride) | 10 mg | 3192 |
| Cayman2015 | 14111 | 5-MAPDB (hydrochloride) | 5 mg | 2044 |
| Cayman2015 | 14114 | Nrf2 (N-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14115 | NRG-3 (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14115 | NRG-3 (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14115 | NRG-3 (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14116 | L-Thyroxine | 1 g | 938 |
| Cayman2015 | 14116 | L-Thyroxine | 5 g | 3920 |
| Cayman2015 | 14116 | L-Thyroxine | 500 mg | 490 |
| Cayman2015 | 14117 | Adropin Monoclonal Antibody (Clone CC1133F5) | 200 μg | 4186 |
| Cayman2015 | 14117 | Adropin Monoclonal Antibody (Clone CC1133F5) | 50 μg | 1330 |
| Cayman2015 | 14118 | Caffeine | 1 g | 266 |
| Cayman2015 | 14118 | Caffeine | 5 g | 420 |
| Cayman2015 | 14119 | Bromosporine | 1 mg | 546 |
| Cayman2015 | 14119 | Bromosporine | 10 mg | 2730 |
| Cayman2015 | 14119 | Bromosporine | 25 mg | 6146 |
| Cayman2015 | 14119 | Bromosporine | 5 mg | 1498 |
| Cayman2015 | 14121 | ZLN005 | 10 mg | 938 |
| Cayman2015 | 14121 | ZLN005 | 25 mg | 2212 |
| Cayman2015 | 14121 | ZLN005 | 5 mg | 490 |
| Cayman2015 | 14121 | ZLN005 | 50 mg | 3920 |
| Cayman2015 | 14122 | CID-2858522 | 1 mg | 406 |
| Cayman2015 | 14122 | CID-2858522 | 10 mg | 1428 |
| Cayman2015 | 14122 | CID-2858522 | 25 mg | 3052 |
| Cayman2015 | 14122 | CID-2858522 | 5 mg | 812 |
| Cayman2015 | 14123 | KC7F2 | 10 mg | 1008 |
| Cayman2015 | 14123 | KC7F2 | 5 mg | 630 |
| Cayman2015 | 14123 | KC7F2 | 50 mg | 3780 |
| Cayman2015 | 14125 | Clofarabine | 10 mg | 672 |
| Cayman2015 | 14125 | Clofarabine | 100 mg | 4802 |
| Cayman2015 | 14125 | Clofarabine | 5 mg | 420 |
| Cayman2015 | 14125 | Clofarabine | 50 mg | 3150 |
| Cayman2015 | 14126 | Cycloheximide | 1 g | 560 |
| Cayman2015 | 14126 | Cycloheximide | 100 mg | 280 |
| Cayman2015 | 14127 | Febuxostat | 10 mg | 1204 |
| Cayman2015 | 14127 | Febuxostat | 25 mg | 2842 |
| Cayman2015 | 14127 | Febuxostat | 5 mg | 630 |
| Cayman2015 | 14127 | Febuxostat | 50 mg | 5040 |
| Cayman2015 | 14128 | Fludarabine | 10 mg | 602 |
| Cayman2015 | 14128 | Fludarabine | 25 mg | 1316 |
| Cayman2015 | 14128 | Fludarabine | 5 mg | 350 |
| Cayman2015 | 14128 | Fludarabine | 50 mg | 1750 |
| Cayman2015 | 14129 | Topotecan (hydrochloride) | 10 mg | 476 |
| Cayman2015 | 14129 | Topotecan (hydrochloride) | 25 mg | 1092 |
| Cayman2015 | 14129 | Topotecan (hydrochloride) | 5 mg | 336 |
| Cayman2015 | 14129 | Topotecan (hydrochloride) | 50 mg | 2016 |
| Cayman2015 | 14131 | IDH1 (human recombinant) | 100 μg | 6300 |
| Cayman2015 | 14131 | IDH1 (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14131 | IDH1 (human recombinant) | 50 μg | 3332 |
| Cayman2015 | 14132 | IDH1 R132H mutant (human recombinant) | 100 μg | 6300 |
| Cayman2015 | 14132 | IDH1 R132H mutant (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14132 | IDH1 R132H mutant (human recombinant) | 50 μg | 3332 |
| Cayman2015 | 14133 | CECR2 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14133 | CECR2 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14133 | CECR2 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14134 | JMJD2A tudor domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14134 | JMJD2A tudor domains (human recombinant) | 25 μg | 1456 |
| Cayman2015 | 14134 | JMJD2A tudor domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14135 | NSD3 (human recombinant) | 100 μg | 9436 |
| Cayman2015 | 14135 | NSD3 (human recombinant) | 25 μg | 2506 |
| Cayman2015 | 14135 | NSD3 (human recombinant) | 50 μg | 4760 |
| Cayman2015 | 14136 | SMN tudor domain (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14136 | SMN tudor domain (human recombinant) | 25 μg | 1456 |
| Cayman2015 | 14136 | SMN tudor domain (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14138 | DL-Cathinone (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 14138 | DL-Cathinone (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 14138 | DL-Cathinone (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 14139 | JNJ-10397049 | 1 mg | 490 |
| Cayman2015 | 14139 | JNJ-10397049 | 10 mg | 2506 |
| Cayman2015 | 14139 | JNJ-10397049 | 5 mg | 1722 |
| Cayman2015 | 14140 | TCPOBOP | 10 mg | 882 |
| Cayman2015 | 14140 | TCPOBOP | 25 mg | 1722 |
| Cayman2015 | 14140 | TCPOBOP | 5 mg | 490 |
| Cayman2015 | 14140 | TCPOBOP | 50 mg | 3192 |
| Cayman2015 | 14147 | 5-fluoro NNEI | 1 mg | 910 |
| Cayman2015 | 14147 | 5-fluoro NNEI | 10 mg | 7280 |
| Cayman2015 | 14147 | 5-fluoro NNEI | 5 mg | 4130 |
| Cayman2015 | 14152 | Quetiapine (hemifumarate) | 1 g | 350 |
| Cayman2015 | 14152 | Quetiapine (hemifumarate) | 10 g | 2450 |
| Cayman2015 | 14152 | Quetiapine (hemifumarate) | 25 g | 4382 |
| Cayman2015 | 14152 | Quetiapine (hemifumarate) | 5 g | 1316 |
| Cayman2015 | 14153 | Entacapone | 10 mg | 490 |
| Cayman2015 | 14153 | Entacapone | 100 mg | 2450 |
| Cayman2015 | 14153 | Entacapone | 25 mg | 854 |
| Cayman2015 | 14153 | Entacapone | 50 mg | 1596 |
| Cayman2015 | 14154 | Floxuridine | 100 mg | 1134 |
| Cayman2015 | 14154 | Floxuridine | 50 mg | 630 |
| Cayman2015 | 14154 | Floxuridine | 500 mg | 5362 |
| Cayman2015 | 14155 | Indirubin | 10 mg | 1204 |
| Cayman2015 | 14155 | Indirubin | 25 mg | 2842 |
| Cayman2015 | 14155 | Indirubin | 5 mg | 630 |
| Cayman2015 | 14155 | Indirubin | 50 mg | 5040 |
| Cayman2015 | 14156 | SD 169 | 10 mg | 686 |
| Cayman2015 | 14156 | SD 169 | 25 mg | 1624 |
| Cayman2015 | 14156 | SD 169 | 5 mg | 406 |
| Cayman2015 | 14157 | Polymyxin B (sulfate) | 1 g | 742 |
| Cayman2015 | 14157 | Polymyxin B (sulfate) | 5 g | 2450 |
| Cayman2015 | 14157 | Polymyxin B (sulfate) | 500 mg | 490 |
| Cayman2015 | 14158 | (±)-β-Hydroxybutyrate-d4 (sodium salt) | 1 mg | 406 |
| Cayman2015 | 14158 | (±)-β-Hydroxybutyrate-d4 (sodium salt) | 10 mg | 3248 |
| Cayman2015 | 14158 | (±)-β-Hydroxybutyrate-d4 (sodium salt) | 5 mg | 1834 |
| Cayman2015 | 14159 | Daunorubicin (hydrochloride) | 10 mg | 980 |
| Cayman2015 | 14159 | Daunorubicin (hydrochloride) | 100 mg | 5782 |
| Cayman2015 | 14159 | Daunorubicin (hydrochloride) | 5 mg | 546 |
| Cayman2015 | 14159 | Daunorubicin (hydrochloride) | 50 mg | 3010 |
| Cayman2015 | 14160 | Acyclovir | 100 mg | 1568 |
| Cayman2015 | 14160 | Acyclovir | 25 mg | 490 |
| Cayman2015 | 14160 | Acyclovir | 50 mg | 882 |
| Cayman2015 | 14160 | Acyclovir | 500 mg | 6860 |
| Cayman2015 | 14161 | Glycitin | 10 mg | 1540 |
| Cayman2015 | 14161 | Glycitin | 25 mg | 3248 |
| Cayman2015 | 14161 | Glycitin | 5 mg | 812 |
| Cayman2015 | 14161 | Glycitin | 50 mg | 6090 |
| Cayman2015 | 14162 | Glycitein | 10 mg | 1204 |
| Cayman2015 | 14162 | Glycitein | 25 mg | 2044 |
| Cayman2015 | 14162 | Glycitein | 5 mg | 630 |
| Cayman2015 | 14162 | Glycitein | 50 mg | 3780 |
| Cayman2015 | 14163 | Temozolomide | 10 mg | 546 |
| Cayman2015 | 14163 | Temozolomide | 100 mg | 2184 |
| Cayman2015 | 14163 | Temozolomide | 25 mg | 756 |
| Cayman2015 | 14163 | Temozolomide | 50 mg | 1372 |
| Cayman2015 | 14164 | Trilostane | 10 mg | 1064 |
| Cayman2015 | 14164 | Trilostane | 5 mg | 560 |
| Cayman2015 | 14164 | Trilostane | 50 mg | 4480 |
| Cayman2015 | 14165 | A-834735 degradant | 1 mg | 1330 |
| Cayman2015 | 14165 | A-834735 degradant | 10 mg | 6650 |
| Cayman2015 | 14165 | A-834735 degradant | 5 mg | 3654 |
| Cayman2015 | 14166 | BARD1 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14166 | BARD1 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14166 | BARD1 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14167 | BRCA1 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14167 | BRCA1 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14167 | BRCA1 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14168 | ECT2 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14168 | ECT2 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14168 | ECT2 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14169 | LIG4 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14169 | LIG4 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14169 | LIG4 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14170 | MDC1 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14170 | MDC1 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14170 | MDC1 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14171 | TP53BP1 BRCT domains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14171 | TP53BP1 BRCT domains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14171 | TP53BP1 BRCT domains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14172 | 5-methoxy-α-Ethyltryptamine | 10 mg | 1638 |
| Cayman2015 | 14172 | 5-methoxy-α-Ethyltryptamine | 25 mg | 3416 |
| Cayman2015 | 14172 | 5-methoxy-α-Ethyltryptamine | 5 mg | 910 |
| Cayman2015 | 14173 | Naringenin | 1 g | 350 |
| Cayman2015 | 14173 | Naringenin | 10 g | 1512 |
| Cayman2015 | 14173 | Naringenin | 5 g | 1232 |
| Cayman2015 | 14174 | Genistin | 10 mg | 1274 |
| Cayman2015 | 14174 | Genistin | 25 mg | 2352 |
| Cayman2015 | 14174 | Genistin | 5 mg | 672 |
| Cayman2015 | 14174 | Genistin | 50 mg | 4368 |
| Cayman2015 | 14175 | Puerarin | 10 mg | 1736 |
| Cayman2015 | 14175 | Puerarin | 25 mg | 4102 |
| Cayman2015 | 14175 | Puerarin | 5 mg | 910 |
| Cayman2015 | 14175 | Puerarin | 50 mg | 7280 |
| Cayman2015 | 14176 | Idarubicin (hydrochloride) | 1 mg | 392 |
| Cayman2015 | 14176 | Idarubicin (hydrochloride) | 10 mg | 1610 |
| Cayman2015 | 14176 | Idarubicin (hydrochloride) | 5 mg | 952 |
| Cayman2015 | 14178 | Valsartan | 10 mg | 490 |
| Cayman2015 | 14178 | Valsartan | 100 mg | 3920 |
| Cayman2015 | 14178 | Valsartan | 25 mg | 1162 |
| Cayman2015 | 14178 | Valsartan | 50 mg | 2212 |
| Cayman2015 | 14180 | Irinotecan (hydrochloride) | 100 mg | 1820 |
| Cayman2015 | 14180 | Irinotecan (hydrochloride) | 25 mg | 630 |
| Cayman2015 | 14180 | Irinotecan (hydrochloride) | 250 mg | 3850 |
| Cayman2015 | 14180 | Irinotecan (hydrochloride) | 50 mg | 952 |
| Cayman2015 | 14181 | Amlexanox | 10 mg | 980 |
| Cayman2015 | 14181 | Amlexanox | 100 mg | 7252 |
| Cayman2015 | 14181 | Amlexanox | 5 mg | 518 |
| Cayman2015 | 14181 | Amlexanox | 50 mg | 4144 |
| Cayman2015 | 14182 | α-Pyrrolidinopentiothiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14182 | α-Pyrrolidinopentiothiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14182 | α-Pyrrolidinopentiothiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14183 | EBPC | 1 mg | 350 |
| Cayman2015 | 14183 | EBPC | 10 mg | 1582 |
| Cayman2015 | 14183 | EBPC | 5 mg | 1050 |
| Cayman2015 | 14184 | Memantine (hydrochloride) | 10 mg | 280 |
| Cayman2015 | 14184 | Memantine (hydrochloride) | 100 mg | 1400 |
| Cayman2015 | 14184 | Memantine (hydrochloride) | 25 mg | 560 |
| Cayman2015 | 14184 | Memantine (hydrochloride) | 50 mg | 840 |
| Cayman2015 | 14185 | Torin 2 | 10 mg | 2128 |
| Cayman2015 | 14185 | Torin 2 | 25 mg | 4984 |
| Cayman2015 | 14185 | Torin 2 | 5 mg | 1330 |
| Cayman2015 | 14186 | D-NMMA (acetate) | 100 mg | 4095 |
| Cayman2015 | 14186 | D-NMMA (acetate) | 25 mg | 1470 |
| Cayman2015 | 14186 | D-NMMA (acetate) | 5 mg | 585 |
| Cayman2015 | 14187 | S14161 | 1 mg | 975 |
| Cayman2015 | 14187 | S14161 | 5 mg | 4395 |
| Cayman2015 | 14188 | Chrysomycin A | 1 mg | 5265 |
| Cayman2015 | 14188 | Chrysomycin A | 250 μg | 2025 |
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......几十家国外公司授权代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批发
